# Halftime Health

> Physician-supervised peptide, hormone, and longevity medicine built from your own bloodwork. At-home 60+ biomarker testing, licensed physicians, compounded protocols from licensed 503A compounding pharmacies, available in 44 states and Washington, D.C.

Halftime Health is a telehealth platform for adults in their 30s, 40s, and 50s who want evidence-based peptide, hormone, and metabolic protocols. Every protocol is prescribed by a licensed physician after lab review. The Learning Center below is a library of plain-English, clinically reviewed guides; all content is educational and not a substitute for medical advice.

## Key pages
- [How it works](https://www.halftime.health/how-it-works): the process from at-home blood test to physician-confirmed protocol.
- [Blood testing](https://www.halftime.health/blood-testing): the 60+ biomarker at-home panel.
- [Membership](https://www.halftime.health/membership): plans and pricing.
- [Learning Center](https://www.halftime.health/learning): 638 guides on peptides, hormones, longevity, labs, and compounding.

## Longevity
- [Alpha-lipoic acid and aging: what research shows](https://www.halftime.health/learning-center/alpha-lipoic-acid-and-aging): Alpha-lipoic acid is an antioxidant made in the mitochondria, and levels fall with age. Here is what it is, how it works, and what research shows.
- [Autophagy FAQ: the cellular cleanup questions answered](https://www.halftime.health/learning-center/autophagy-faqs): Autophagy is your cells' recycling program. This FAQ covers what it is, how fasting and exercise trigger it, and what the research supports — in plain terms.
- [Fasting and autophagy: what the timing research supports](https://www.halftime.health/learning-center/autophagy-fasting-timing): How long do you need to fast for autophagy? Here is what the timing research supports, what is still unknown, and why the online hour-numbers oversimplify it.
- [How autophagy works: the mTOR and AMPK pathways](https://www.halftime.health/learning-center/autophagy-mechanism): How autophagy works in plain English: the mTOR and AMPK switches that tell your cells when to recycle worn-out parts, and what the research shows.
- [Autophagy explained: what cellular cleanup is and why it matters](https://www.halftime.health/learning-center/autophagy-what-it-is): Autophagy is the body's recycling crew — clearing damaged parts inside cells so the healthy ones can keep working. Why longevity researchers care.
- [Biological age tests: which ones have evidence, which don't](https://www.halftime.health/learning-center/biological-age-tests-evidence): Are biological age tests accurate? A plain-English look at epigenetic clocks, blood-based tests, and telomere kits — which have real evidence and which don't.
- [Boron and bone health: what research shows](https://www.halftime.health/learning-center/boron-and-bone-health): Boron is a trace mineral studied for effects on calcium, magnesium, and bone. Here's what the research shows, typical intake, and the upper limit.
- [BPC-157 and the brain-gut axis: what the research describes](https://www.halftime.health/learning-center/bpc-157-brain-gut-axis-research): BPC-157 and the brain-gut axis in plain English: what the rodent research describes about gut healing, vagal signaling, and why human evidence is still limited.
- [BPC-157 and gut health: what the research shows](https://www.halftime.health/learning-center/bpc-157-gut-healing): BPC-157 was discovered in gastric juice, and the gastrointestinal literature is its home territory. Here is an honest summary of what the preclinical research shows — and what it does not.
- [BPC-157 human trials: what has actually been studied](https://www.halftime.health/learning-center/bpc-157-human-trials-what-exists): BPC-157 has decades of animal data but a much smaller human trial base. Here is exactly what has been studied in humans, what hasn't, and how to read the gap.
- [BPC-157: 30 years of animal research, what it tells us](https://www.halftime.health/learning-center/bpc-157-literature-30-years-review): BPC-157 has 30 years of animal research in plain English: a peptide derived from gastric juice, studied for tissue repair in rodents, with limited human clinical data.
- [BPC-157 and TB-500: why these two are often discussed together](https://www.halftime.health/learning-center/bpc-157-tb-500-combination-rationale): Why BPC-157 and TB-500 are often discussed together in tissue-repair research: the mechanisms, the overlap, and the Category 2 regulatory reality.
- [BPC-157 and TB-500: why these two peptides are studied together](https://www.halftime.health/learning-center/bpc-157-tb-500-stack): BPC-157 and TB-500 are often discussed together in tissue-repair contexts because their proposed mechanisms are complementary. Here is the research rationale — and why both are currently Category 2.
- [BPC-157 for tissue repair and recovery: the evidence](https://www.halftime.health/learning-center/bpc-157-tissue-repair): BPC-157 has been investigated in animal models of tendon, ligament, and muscle injury. Here is what the preclinical research actually shows — and the human evidence gap that remains.
- [Calcium alpha-ketoglutarate and the longevity research](https://www.halftime.health/learning-center/calcium-alpha-ketoglutarate-longevity): Calcium alpha-ketoglutarate (Ca-AKG) has drawn longevity interest from mouse studies. Here is what the animal and early human data actually show.
- [Cardiolipin: the fat that keeps your mitochondria running](https://www.halftime.health/learning-center/cardiolipin-inner-mitochondrial-membrane): Cardiolipin is a special fat in the inner mitochondrial membrane that keeps energy production efficient. Here is what it does and why it matters with age.
- [Cellular senescence and senolytics: what the research shows](https://www.halftime.health/learning-center/cellular-senescence-and-senolytics-what-the-longevity-research-shows): Senescent cells are aging cells that stop dividing but won't die. Here is what cellular senescence is, what senolytics aim to do, and what research shows.
- [Centenarian biology: what longevity outliers actually share](https://www.halftime.health/learning-center/centenarian-biology-longevity-outliers): Centenarian biology — what people who live to 100 actually share, where the evidence is solid, and what the lessons mean for the rest of us.
- [Copper balance and aging: the trace mineral explained](https://www.halftime.health/learning-center/copper-balance-and-aging): Copper is a trace mineral the body needs in tiny amounts and balances against zinc. Here's what copper does, how it's carried, and why balance matters.
- [Creatine for women: what the research shows for muscle, bone, and cognition](https://www.halftime.health/learning-center/creatine-for-women-muscle-bone-cognition): A plain-English summary of the creatine research for women — what the data shows on muscle, bone, and cognition, and what older assumptions got wrong.
- [Creatine for women: what the research shows for muscle, bone, and cognition](https://www.halftime.health/learning-center/creatine-for-women-research-muscle-bone-cognition): Creatine is one of the most studied supplements in sports nutrition. For midlife women, the literature on muscle, bone, and brain is now substantial.
- [Creatine for women: what the research shows for muscle, bone, and brain](https://www.halftime.health/learning-center/creatine-for-women-what-the-published-research-shows-for-muscle-bone-and-cogniti): Creatine isn't just for male lifters. Here's what the published research shows for women's muscle, bone, and brain health, explained in plain English.
- [DSIP (delta sleep-inducing peptide): what the research says](https://www.halftime.health/learning-center/dsip-sleep-peptide): DSIP was isolated in 1977 and has mixed sleep-architecture data in animals and humans. As of 2026, it is not available via 503A compounding pharmacies.
- [DSIP and sleep quality: what the research actually shows](https://www.halftime.health/learning-center/dsip-sleep-quality-research): DSIP explained: what delta sleep-inducing peptide is, what the research shows on sleep quality, and where the evidence remains thin. Educational only.
- [Who asks about DSIP and the sleep questions behind it](https://www.halftime.health/learning-center/dsip-who-asks): DSIP (delta sleep-inducing peptide) is an old research peptide tied to sleep. Here's who asks about DSIP, what the science shows, and its regulatory status.
- [Environmental toxins and hormones: what the research shows](https://www.halftime.health/learning-center/environmental-toxins-and-hormonal-health-what-the-endocrine-disruptor-literature-shows): Endocrine disruptors are everyday chemicals that can interfere with hormones. Here is what the research shows and what is still uncertain, in plain English.
- [Epigenetic clocks: can a test measure your biological age?](https://www.halftime.health/learning-center/epigenetic-clocks-2026-grimage): Epigenetic clocks read DNA methylation to estimate biological age. Here is how the Horvath clock, GrimAge, and DunedinPACE work and what the research shows.
- [Epitalon and sleep: the pineal-gland connection](https://www.halftime.health/learning-center/epitalon-sleep-pineal-gland): Epitalon and sleep: how the pineal-gland peptide may influence melatonin rhythm, what small studies report, and where it sits in FDA Category 2 access.
- [Epitalon and telomere extension: reading the research carefully](https://www.halftime.health/learning-center/epitalon-telomere-extension-research-review): Epitalon is a four-amino-acid peptide tied to telomere length and pineal-gland research. A careful read of what the studies do and do not show — and what Category 2 status means.
- [Epitalon and the telomere research](https://www.halftime.health/learning-center/epitalon-telomere-research): Epitalon is a tetrapeptide studied primarily in Russian research for telomerase activation in vitro. US clinical data is sparse. It is not available via 503A compounding pharmacies.
- [Who asks about epitalon and the longevity questions behind it](https://www.halftime.health/learning-center/epitalon-who-asks): People ask about epitalon after reading about telomeres and aging. Here is what the research shows, what it does not, and its FDA status in 2026.
- [Ergothioneine: the 'longevity vitamin' from mushrooms](https://www.halftime.health/learning-center/ergothioneine-longevity-antioxidant): Ergothioneine is a diet-derived antioxidant from mushrooms that researchers call a possible longevity vitamin. Here is what the science actually shows.
- [Estrogen, muscle, and metabolic health: the perimenopause connection](https://www.halftime.health/learning-center/estrogen-muscle-and-metabolic-health-the-perimenopause-connection): Estrogen does more than reproduction. It quietly supports muscle, insulin sensitivity, and bone. Here is what happens when it falls in perimenopause.
- [Exerkines: the molecules exercise releases, explained](https://www.halftime.health/learning-center/exerkines-klotho-irisin-explained): Exerkines are signaling molecules your body releases during exercise. Here's what klotho, irisin, and MOTS-c do — and what the research actually shows.
- [Fisetin: the plant senolytic researchers study](https://www.halftime.health/learning-center/fisetin-senolytic-flavonoid): Fisetin is a plant flavonoid studied as a senolytic — a compound that clears worn-out cells. Here's what it is, where it's found, and what the data shows.
- [Full-body MRI screening: who it helps and who it scares](https://www.halftime.health/learning-center/full-body-mri-screening-2026): Is a full-body MRI worth it? A plain-English look at what these scans detect, the incidental-findings problem, and who benefits versus who just gets scared.
- [Glucosamine and longevity: what the mortality data shows](https://www.halftime.health/learning-center/glucosamine-longevity-signal): Beyond joints, glucosamine use has been linked to lower mortality in large studies. Here is what the longevity data shows and what it cannot prove yet.
- [GlyNAC: glycine plus NAC and the glutathione question](https://www.halftime.health/learning-center/glynac-glycine-nac-longevity): GlyNAC pairs glycine with NAC, the two building blocks of glutathione. Here is what a small Baylor trial reported in older adults — and the caveats.
- [Grip strength FAQ: the longevity testing questions answered](https://www.halftime.health/learning-center/grip-strength-faqs): What is normal grip strength by age, how to test it at home, and what it signals about long-term health. Evidence-based answers to common questions.
- [Grip strength as a longevity marker: what the research shows](https://www.halftime.health/learning-center/grip-strength-longevity): Grip strength is one of the most replicated longevity predictors in clinical research. Here is what it actually measures and what the studies found.
- [Grip Strength and Mortality: What the Research Shows](https://www.halftime.health/learning-center/grip-strength-research): Grip strength and mortality are linked in large studies: a weaker grip tracks with higher death risk, making it a simple, low-cost health marker.
- [Grip strength: why a simple squeeze predicts healthy aging](https://www.halftime.health/learning-center/grip-strength-why-a-simple-squeeze-predicts-healthy-aging): Grip strength is one of the simplest predictors of healthy aging. Here is what a hand squeeze reveals about your whole body and how to build it.
- [The hallmarks of aging: how the field maps biological decline](https://www.halftime.health/learning-center/hallmarks-of-aging): The hallmarks of aging in plain English — the 12 biological processes longevity researchers track, and why this framework guides modern preventive medicine.
- [The hallmarks of aging — and which peptides target which](https://www.halftime.health/learning-center/hallmarks-of-aging-peptides-map): Researchers describe twelve hallmarks of aging. Here is which ones the most-studied peptides actually engage with — and where the evidence stops.
- [Healthspan vs lifespan: what the longevity field actually studies](https://www.halftime.health/learning-center/healthspan-vs-lifespan): Lifespan is how long you live. Healthspan is how long you live well. Here is what the longevity field is actually studying — and why the distinction matters.
- [The Huberman peptide list: what he's actually said and what the data shows](https://www.halftime.health/learning-center/huberman-peptide-list-what-he-said): Andrew Huberman has discussed several peptides on his podcast. Here is what he has actually said, which compounds he's been cautious about, and what the published research supports.
- [IGF-1 LR3: what the research actually shows](https://www.halftime.health/learning-center/igf-1-lr3-research): IGF-1 LR3 is a modified analog of IGF-1 with a longer half-life. Animal model data exists, but human safety evidence is limited. Here's an honest read of the literature.
- [Who Asks About IGF-1 LR3 and the Goals Behind the Question](https://www.halftime.health/learning-center/igf-1-lr3-who-asks): Who searches for IGF-1 LR3 and why? A plain-language look at the muscle-signaling research, its regulatory status, and the trade-offs to weigh first.
- [The IGF-1 trade-off: GH peptides and long-term risk](https://www.halftime.health/learning-center/igf1-tradeoff-gh-peptides-long-term-risk): Higher IGF-1 helps muscle and recovery, but population studies link the top of the range to cancer and mortality signals. Here is what the literature shows.
- [Inflammation as accelerator: how chronic low-grade inflammation drives aging](https://www.halftime.health/learning-center/inflammation-accelerator-aging): Inflammation and aging in plain English: how chronic low-grade inflammation quietly accelerates age-related decline, and which markers reveal it.
- [Klotho, the longevity protein: what the research actually shows](https://www.halftime.health/learning-center/klotho-the-longevity-protein-what-the-research-actually-shows): Klotho is a protein named after the Greek fate who spins life's thread. Here is what it does, why scientists tie it to aging, and what is still unproven.
- [The longevity-clinic boom: telling substance from theater](https://www.halftime.health/learning-center/longevity-clinic-substance-vs-theater): Longevity clinics are booming, and quality varies widely. Here is how to tell evidence-based longevity medicine from expensive theater before you sign up.
- [Longevity Clinics vs Telehealth: How the Models Differ](https://www.halftime.health/learning-center/longevity-clinics-vs-telehealth): Longevity clinics offer in-person, high-touch testing at a premium price. Telehealth longevity care trades the in-person visit for lower cost and wider access.
- [Longevity Drugs vs. Longevity Peptides: How They're Positioned](https://www.halftime.health/learning-center/longevity-drugs-vs-peptides): Rapamycin and metformin have the deepest longevity evidence base. Peptides sit earlier on the research curve. Here is how the two categories are positioned.
- [Longevity science: how to tell evidence from hype](https://www.halftime.health/learning-center/longevity-evidence-vs-hype): Longevity science: a plain-English framework for telling real research from hype. Animal vs human data, sample sizes, surrogates, and what claims actually mean.
- [Longevity medicine FAQ: the questions people actually ask](https://www.halftime.health/learning-center/longevity-faqs): Longevity medicine measures age-related change before it becomes disease. Straight answers on healthspan, evidence, and biological age tests inside.
- [Longevity peptides vs supplements: comparing evidence levels](https://www.halftime.health/learning-center/longevity-peptides-vs-supplements-evidence): Peptides and supplements live on a spectrum of evidence — from rodent-only data to large human trials. Here is how to read the levels without falling for hype.
- [Longevity Research: The Published Evidence Base in 2026](https://www.halftime.health/learning-center/longevity-research-2026): A 2026 snapshot of longevity research, sorted by evidence strength: what is proven in humans, what works in mice, and what is still mechanism only.
- [Who is drawn to longevity medicine and why](https://www.halftime.health/learning-center/longevity-who-asks): Longevity medicine attracts a specific kind of person — not the worried well, but the proactively curious. Here is who seeks it out and why it matters.
- [Magnesium and healthy aging: what the evidence shows](https://www.halftime.health/learning-center/magnesium-and-healthy-aging): Magnesium supports hundreds of body processes. Older adults absorb less and excrete more. Here's what the NIH says about needs, food sources, and forms.
- [MOTS-c and exercise: why physical activity may be a natural secretagogue](https://www.halftime.health/learning-center/mots-c-and-exercise-induced-peptides-why-physical-activity-may-be-a-natural-secretagogue): MOTS-c is a mitochondria-derived peptide that rises with aerobic exercise. Researchers think it may help explain exercise's metabolic and longevity benefits.
- [MOTS-c and exercise: the mitokine that mimics physical activity](https://www.halftime.health/learning-center/mots-c-exercise-mimetic-mitokine): MOTS-c as an exercise mimetic in plain English: a mitochondria-derived peptide that rises with physical activity and signals metabolic flexibility. What the research shows.
- [MOTS-c and longevity: why a mitochondrial peptide has researchers paying attention](https://www.halftime.health/learning-center/mots-c-mitochondria-longevity-research): MOTS-c longevity research in plain English: a 16-amino-acid peptide encoded inside the mitochondria that may signal metabolic flexibility. What the literature actually shows — and what it does not.
- [MOTS-c: the mitochondria-derived peptide in the literature](https://www.halftime.health/learning-center/mots-c-mitochondrial): MOTS-c is a peptide encoded by mitochondrial DNA, discovered in 2015. Animal data shows metabolic and exercise-capacity effects via AMPK. It is Category 2 as of 2026.
- [MOTS-c: the mitochondria-derived peptide explained](https://www.halftime.health/learning-center/mots-c-what-it-is): MOTS-c is a 16-amino-acid peptide encoded inside mitochondrial DNA. Here is what the peptide is, what the metabolic research describes, and its current access status.
- [Who asks about MOTS-c and what they want to understand](https://www.halftime.health/learning-center/mots-c-who-asks): MOTS-c is a mitochondrial-derived peptide tied to metabolism and exercise in research. Here's who asks about it and what the science actually shows.
- [mTOR Explained: The Growth-vs-Repair Switch Rapamycin Targets](https://www.halftime.health/learning-center/mtor-growth-repair-switch): What is mTOR? A plain-English guide to the cellular growth-vs-repair switch rapamycin research targets, and what the longevity evidence actually shows.
- [Myostatin: the body's brake on muscle growth, explained](https://www.halftime.health/learning-center/myostatin-muscle-growth-brake): Myostatin is a protein your body makes to put a brake on muscle growth. Here's what it is, how it works, and what research says about blocking it.
- [NAD+ and peptides: how longevity clinicians are combining protocols](https://www.halftime.health/learning-center/nad-and-peptides-how-longevity-practitioners-are-combining-protocols): Some longevity clinicians combine NAD+ precursors with peptides. Here's the rationale, what the research supports, and what remains theoretical.
- [NAD and aging: what the research actually shows](https://www.halftime.health/learning-center/nad-decline-aging-research): NAD is a molecule your cells need for energy, and it declines with age. Here is what the research shows about NAD, NMN, and NR — and what it does not yet prove.
- [NAD+ IV vs oral precursors: what the delivery research shows](https://www.halftime.health/learning-center/nad-plus-delivery-options): NAD+ IV delivers it straight to blood; oral NMN and NR raise blood NAD+ 22-142% in trials. Here's what the delivery research actually shows.
- [How NAD+ fuels cellular energy and DNA repair](https://www.halftime.health/learning-center/nad-plus-mechanism): NAD+ is the cellular currency for energy production and DNA repair. How the molecule works, why it declines with age, and what the research shows.
- [NAD+ and peptides: how they work in complementary lanes](https://www.halftime.health/learning-center/nad-plus-peptides-complementary): NAD+ supports cellular energy. Peptides act through specific receptors. They are not competitors — they live in different lanes of the longevity conversation.
- [NAD+ Side Effects: What to Know About High-Dose Use](https://www.halftime.health/learning-center/nad-plus-side-effects): NAD+ side effects range from flushing, nausea, and cramping with fast IV use to limited long-term safety data on high-dose NR and NMN supplements.
- [NAD+ vs NMN vs NR: comparing the three approaches](https://www.halftime.health/learning-center/nad-plus-vs-nmn-nr): NAD+, NMN, and NR all aim to refuel the same cellular battery. Here is the plain-English difference between the three, and what human research actually shows.
- [NAD+ explained: coenzyme, not peptide](https://www.halftime.health/learning-center/nad-plus-what-it-is): What is NAD+? A plain-English primer on the coenzyme behind cellular energy, why it declines with age, and why it is not actually a peptide.
- [Osteoporosis prevention starts at 35](https://www.halftime.health/learning-center/osteoporosis-prevention-starts-at-35-what-the-bone-density-research-shows): Your bones peak in your late 20s and slowly decline after. Here is why osteoporosis prevention really starts decades earlier, in plain English.
- [Peptides and Alzheimer's: what the emerging literature describes](https://www.halftime.health/learning-center/peptides-alzheimers-emerging-literature): Peptides and Alzheimer's research in plain English: what the early literature describes, where animal data dominates, and why claims should be cautious.
- [Peptides for sleep: what the evidence actually supports](https://www.halftime.health/learning-center/peptides-for-sleep-evidence-review): Which peptides actually have human sleep evidence and which do not? A plain-English review of DSIP, sermorelin, CJC-1295/ipamorelin, and epitalon.
- [Perimenopause and muscle loss: why the 40s are the critical metabolic window](https://www.halftime.health/learning-center/perimenopause-and-muscle-loss-why-the-40s-are-the-critical-metabolic-window): Women lose muscle faster in their 40s than at any prior decade. Here is why perimenopause changes the math — and what the research says about pushing back.
- [Perimenopause and muscle loss: why the 40s are the critical metabolic window](https://www.halftime.health/learning-center/perimenopause-muscle-loss): Perimenopause accelerates muscle loss for many women. Here is what published research shows about estrogen, lean mass, and the metabolic window of the 40s.
- [What Peter Attia said about gray-market peptides: the full context](https://www.halftime.health/learning-center/peter-attia-gray-market-peptide-ama): Peter Attia has spoken cautiously about peptides without medical supervision. Here's what he's actually said and why it matters for most patients.
- [Protein intake FAQ: the midlife nutrition questions answered](https://www.halftime.health/learning-center/protein-intake-faqs): How much protein in midlife? PROT-AGE recommends 1.0-1.2 g/kg daily, roughly 70-84 grams for a 70 kg adult, spread across meals from plant or animal sources.
- [How Protein Preserves Muscle Through Leucine Signaling](https://www.halftime.health/learning-center/protein-leucine-mechanism): Leucine, an amino acid in protein, acts as a switch that turns on muscle building. Hitting a leucine threshold each meal helps preserve muscle with age.
- [Protein and longevity research: what the evidence supports in 2026](https://www.halftime.health/learning-center/protein-longevity-research): Protein and longevity research is split: the RDA covers deficiency, PROT-AGE backs more for aging muscle, and one mortality link reverses after 65.
- [How much protein you actually need in midlife](https://www.halftime.health/learning-center/protein-midlife-primer): The RDA for protein was set to prevent deficiency — not to protect muscle in midlife. Here's what the research says about how much you actually need.
- [Why intermittent rapamycin dosing is the research focus](https://www.halftime.health/learning-center/rapamycin-intermittent-dosing): Rapamycin is FDA-approved for organ transplants. Learn why researchers study intermittent, weekly rapamycin dosing instead of daily use in longevity research.
- [Rapamycin: the longevity drug researchers watch most](https://www.halftime.health/learning-center/rapamycin-most-watched-2026): Rapamycin is an FDA-approved immunosuppressant studied off-label for healthy aging. Here is what mTOR inhibition is and what the research actually shows.
- [Resistance training vs cardio for women's longevity](https://www.halftime.health/learning-center/resistance-training-vs-cardio-for-womens-longevity-what-the-science-shows): For women's longevity, is lifting or cardio better? The honest answer is both, for different reasons. Here is what the research shows, in plain English.
- [The consequences of sarcopenia: why early action matters](https://www.halftime.health/learning-center/sarcopenia-consequences): Sarcopenia — age-related muscle loss — raises your risk of falls, frailty, and early death. Learn why acting early is the smartest move you can make.
- [Sarcopenia FAQ: the muscle loss questions people ask](https://www.halftime.health/learning-center/sarcopenia-faqs): Sarcopenia FAQ: when it starts, how it's diagnosed, if it's reversible, whether cardio helps, and how it differs from frailty — answered in plain English.
- [How muscle is lost with age: the sarcopenia mechanism](https://www.halftime.health/learning-center/sarcopenia-mechanism): Sarcopenia is the slow loss of muscle and strength with age. Here is the plain-English mechanism behind it, and why the decline speeds up after age 60.
- [Resistance training and protein: the sarcopenia floor](https://www.halftime.health/learning-center/sarcopenia-training-protein): Resistance training plus adequate protein is the evidence-based floor under sarcopenia prevention. The numbers and the mechanism. Educational only.
- [Sarcopenia explained: the muscle loss most people miss](https://www.halftime.health/learning-center/sarcopenia-what-it-is): Sarcopenia is the gradual age-related loss of muscle mass, strength, and function. Here is what it is — and why catching it early matters in plain English.
- [Who is at risk for sarcopenia and the signs to notice](https://www.halftime.health/learning-center/sarcopenia-who-at-risk): Sarcopenia affects roughly 1 in 3 adults over 70, but muscle loss starts decades earlier. Here is who is most at risk and what signs to watch for.
- [Sauna and longevity: what the heat research shows](https://www.halftime.health/learning-center/sauna-heat-exposure-longevity): Sauna use is linked to lower cardiovascular and all-cause mortality in large studies. Here is what the heat-exposure research shows and what it cannot prove.
- [Selank: a Russian research compound with anxiolytic history](https://www.halftime.health/learning-center/selank-anxiety-research): Selank is a heptapeptide analog of tuftsin with Russian clinical data for anxiety. It is not FDA-evaluated and is not available via 503A compounding pharmacies as of 2026.
- [Selank and anxiety research: what the Russian studies actually show](https://www.halftime.health/learning-center/selank-anxiety-russian-studies): Selank and anxiety: what the Russian clinical literature on this Phase-2 peptide actually reports, the mechanism in plain English, and current access status.
- [Who Asks About Selank and the Cognitive Questions Behind the Search](https://www.halftime.health/learning-center/selank-who-asks): Who searches for Selank and why? A plain-language look at the anxiolytic research, its FDA Category 2 status, and what to know before considering it.
- [Selenium and healthy aging: the antioxidant mineral](https://www.halftime.health/learning-center/selenium-and-healthy-aging): Selenium is a trace mineral your body uses to build antioxidant proteins. Here's what selenium does, how it links to aging, and how much you need.
- [Semax: a nootropic peptide under FDA reclassification](https://www.halftime.health/learning-center/semax-cognition-research): Semax is an ACTH(4-10) heptapeptide analog with Russian clinical use for stroke and cognition. It is Category 2 in the US and not available via 503A pharmacies as of 2026.
- [Who Asks About Semax and What Draws People to the Topic](https://www.halftime.health/learning-center/semax-who-asks): Who searches for Semax and why? A plain-language look at the cognitive research, its Category 2 status, and what to know before considering it.
- [Senolytics: Clearing 'Zombie Cells' and the Dasatinib-Quercetin Story](https://www.halftime.health/learning-center/senolytics-zombie-cells-dq): What are senolytics? A plain-English look at senescent 'zombie cells' and the dasatinib-plus-quercetin research — what trials show and what's still unproven.
- [Sleep Peptides vs Melatonin: How the Approaches Differ](https://www.halftime.health/learning-center/sleep-peptides-vs-melatonin): Sleep peptides vs melatonin: how DSIP and melatonin differ in evidence, regulatory status, and what each one is actually studied to do for sleep.
- [Sleep quality and aging: what the research actually shows](https://www.halftime.health/learning-center/sleep-quality-aging-research): Sleep changes measurably with age — less deep sleep, more fragmentation, lighter mornings. Here is what the research shows and how it interacts with the rest of healthy aging.
- [Spermidine: the autophagy nutrient in food](https://www.halftime.health/learning-center/spermidine-autophagy-food-sources): Spermidine is a natural compound in food that researchers study for autophagy and longevity. Here's what it is, where it's found, and what the data shows.
- [SS-31 (elamipretide): the mitochondria-targeting peptide in trials](https://www.halftime.health/learning-center/ss-31-elamipretide-the-mitochondria-targeting-peptide-in-trials): SS-31, or elamipretide, is a peptide studied for failing mitochondria. Here is what it targets, what the trials show so far, and why it is not approved yet.
- [Sulforaphane and Nrf2: the broccoli-sprout antioxidant](https://www.halftime.health/learning-center/sulforaphane-nrf2-longevity): Sulforaphane is a broccoli-sprout compound studied for switching on the body's Nrf2 antioxidant defenses. Here is what the research actually shows.
- [Taurine and aging: what the 2023 research actually found](https://www.halftime.health/learning-center/taurine-and-aging-what-the-2023-research-actually-found): A 2023 study put taurine on the longevity map. Here is what the research showed in animals, what it did not show in humans, and how to read the headlines.
- [TB-500 for tissue repair: what the research shows](https://www.halftime.health/learning-center/tb-500-tissue-repair): TB-500 has been investigated in animal models of musculoskeletal, cardiac, and dermal injury. Here is what the preclinical research shows — and the human evidence gap that remains.
- [TB-500 and tissue repair: separating signal from noise](https://www.halftime.health/learning-center/tb-500-tissue-repair-signal-noise): TB-500 (thymosin beta-4) has decades of animal data on tissue repair but limited human evidence. Here is what the literature shows — and what it does not.
- [Tesamorelin and visceral fat research](https://www.halftime.health/learning-center/tesamorelin-visceral-fat): Tesamorelin (Egrifta) is FDA-approved for HIV-associated lipodystrophy. Here's what published trials show about its effects on visceral adipose tissue.
- [Thymosin alpha-1 dosing: what published protocols describe](https://www.halftime.health/learning-center/thymosin-alpha-1-dosing): Published thymosin alpha-1 dosing comes from international Zadaxin trials. Here is what the trial protocols describe — and why dosing is a clinician decision.
- [Thymosin alpha-1 FAQ: the top questions answered](https://www.halftime.health/learning-center/thymosin-alpha-1-faqs): Thymosin alpha-1 FAQ — what it is, how it works, who it is for, side effects, and regulatory status. Plain-English answers to the most common Tα1 questions.
- [Thymosin alpha-1 research: where it has been studied](https://www.halftime.health/learning-center/thymosin-alpha-1-research): Thymosin alpha-1 has decades of clinical research behind it, mostly in infectious disease and immune contexts. Here is what the thymosin alpha-1 research base actually shows.
- [Thymosin alpha-1 side effects and contraindications](https://www.halftime.health/learning-center/thymosin-alpha-1-side-effects): Thymosin alpha-1 side effects in trials are usually mild — injection-site soreness, mild flu-like feeling, occasional rash. Plus the contraindications.
- [Thymosin alpha-1: what this immune peptide is](https://www.halftime.health/learning-center/thymosin-alpha-1-what-it-is): Thymosin alpha-1 in plain English — what it is, where it comes from in the body, and why clinicians are paying attention to this immune-modulating peptide.
- [The thymus and aging: why thymosin research matters more at 50](https://www.halftime.health/learning-center/thymus-aging-thymosin-research): The thymus shrinks steadily after puberty. By age 50, most of it is replaced by fat. Here is what that means for immune aging — and what the thymosin research explores.
- [Urolithin A and mitophagy: what the longevity research shows](https://www.halftime.health/learning-center/urolithin-a-and-mitophagy-what-the-longevity-research-shows): Urolithin A is a gut-made compound studied for clearing worn-out mitochondria. Here is what mitophagy means and what early human research actually shows.
- [Vitamin B12 and aging: what the research shows](https://www.halftime.health/learning-center/vitamin-b12-and-aging): Vitamin B12 absorption drops with age, so deficiency is common in older adults. Here is what B12 does, why it falls, and what the research shows.
- [Vitamin D and healthy aging: what the research actually shows](https://www.halftime.health/learning-center/vitamin-d-and-healthy-aging-what-the-research-actually-shows): Vitamin D shapes bone, muscle, and immune health as we age. Here is what the research actually shows, what the test means, and where the hype runs ahead.
- [Vitamin E tocotrienols and healthy aging](https://www.halftime.health/learning-center/vitamin-e-tocotrienols-and-aging): Vitamin E tocotrienols are a less common form of vitamin E studied as antioxidants. Here's how they differ from tocopherols and what aging research shows.
- [Vitamin K2 and arterial aging: what research shows](https://www.halftime.health/learning-center/vitamin-k2-arterial-aging): Vitamin K2 (menaquinone) helps activate proteins that manage calcium. Here's what the research shows about vitamin K2 and arterial aging, told plainly.
- [VO2 Max FAQ: The Fitness and Longevity Questions Answered](https://www.halftime.health/learning-center/vo2-max-faqs): VO2 max FAQ: what counts as a good score by age, how often to retest, and what the longevity research actually shows about this fitness metric.
- [How VO2 max reflects heart and mitochondrial capacity](https://www.halftime.health/learning-center/vo2-max-mechanism): VO2 max measures how much oxygen your body uses at peak effort. Learn how your heart and mitochondria determine it — and what training can change.
- [VO2 Max and Longevity: What the Research Shows](https://www.halftime.health/learning-center/vo2-max-research): VO2 max and longevity are tightly linked: research ties higher cardiorespiratory fitness to lower mortality, with the least-fit facing several times the risk.
- [How to improve VO2 max: zone 2 and interval training](https://www.halftime.health/learning-center/vo2-max-training): How to improve VO2 max: combine easy zone 2 volume with short, hard intervals like the Norwegian 4x4 in one weekly training plan, not either alone.
- [VO2 max explained: what this longevity metric measures](https://www.halftime.health/learning-center/vo2-max-what-it-is): VO2 max is the most-studied longevity number you can measure. It estimates how much oxygen your body can use per minute — a strong predictor of lifespan.
- [Who should track VO2 max and at what frequency](https://www.halftime.health/learning-center/vo2-max-who-tracks): Who benefits most from tracking VO2 max, how often to test it, and why this single metric predicts longevity better than almost any other number.
- [What Matt Kaeberlein's longevity research tells us about tissue repair](https://www.halftime.health/learning-center/what-matt-kaeberleins-longevity-research-tells-us-about-tissue-repair-peptides): Matt Kaeberlein's work at UW spans rapamycin, aging clocks, and tissue repair. Here's what his research framework tells us about peptide-assisted recovery.
- [Zinc and immune aging: what the research shows](https://www.halftime.health/learning-center/zinc-and-immune-aging): Zinc helps run the immune system, and older adults are more likely to fall short. Here's what research says about zinc and immune aging, plus honest limits.
- [Zone 2 training: the longevity workout most people skip](https://www.halftime.health/learning-center/zone-2-training-the-longevity-workout-most-people-skip): Zone 2 training is easy, conversational cardio that builds your aerobic base. Here is what it is, how it works, and why it matters for healthy aging.
- [Zone 2 cardio explained: what it is and who it is for](https://www.halftime.health/learning-center/zone2-faqs): Zone 2 cardio explained: what heart rate it targets, why it builds metabolic health, and who benefits most from making it a regular training priority.
- [Zone 2 training: how to actually do it](https://www.halftime.health/learning-center/zone2-implementation): Zone 2 training works — if you actually stay in it. Here's how to find your zone, pick a modality, and avoid the #1 mistake that makes it useless.
- [How Zone 2 Training Improves Mitochondrial Efficiency](https://www.halftime.health/learning-center/zone2-mechanism): Zone 2 training works by recruiting mitochondria-rich muscle fibers, but a 2025 review found its edge over harder training is not established.
- [Zone 2 training explained: why this pace matters](https://www.halftime.health/learning-center/zone2-what-it-is): Zone 2 is the pace at which your body burns fat efficiently and builds aerobic capacity. Here's what it is, how to find it, and why scientists love it.

## Peptide 101
- [Agonist vs antagonist: how a peptide turns a receptor on or off](https://www.halftime.health/learning-center/agonist-vs-antagonist-how-a-peptide-turns-a-receptor-on-or-off): An agonist switches a receptor on; an antagonist blocks it. Here is the plain-English difference, with a key-and-lock analogy and why it matters for peptides.
- [Are peptides safe? What the answer actually depends on](https://www.halftime.health/learning-center/are-peptides-safe-what-it-depends-on): Are peptides safe? The honest answer depends on the compound, the source, the dose, and the person. Here's the clinical path vs unregulated buying.
- [Are peptides steroids? Clearing up the biggest misconception](https://www.halftime.health/learning-center/are-peptides-steroids-misconception): Peptides and steroids are completely different — different structures, mechanisms, and legal status. Here's why people confuse them and what sets them apart.
- [Where biologics end and peptides begin: the size spectrum](https://www.halftime.health/learning-center/biologics-vs-peptides-size-spectrum): Peptides and proteins are the same chemistry at different sizes. See where the FDA draws the line, measured in amino acids and daltons, and why it matters.
- [Why 'boosting' immunity is the wrong mental model](https://www.halftime.health/learning-center/boosting-immunity-wrong-model): Can you boost your immune system? A plain-English look at why 'boosting' is the wrong mental model, what balance really means, and what the science supports.
- [How BPC-157 works: the mechanism behind the research](https://www.halftime.health/learning-center/bpc-157-mechanism): BPC-157's proposed mechanisms span angiogenesis, nitric oxide signaling, growth factor upregulation, and gut mucosal protection. Here is what the preclinical literature actually shows.
- [BPC-157 research: what the published literature shows](https://www.halftime.health/learning-center/bpc-157-research): BPC-157 has been studied for over thirty years, mostly in animals. Here is the BPC-157 research base today: what is well-described, what is still open, and where humans fit in.
- [BPC-157 research: what the literature actually says](https://www.halftime.health/learning-center/bpc-157-research-review): An honest summary of the BPC-157 research landscape: where the evidence is strong, where it is limited, and what the open questions are. Useful primer for clinicians, patients, and anyone parsing the online discourse.
- [BPC-157 side effects and safety profile](https://www.halftime.health/learning-center/bpc-157-side-effects): What is known and not known about the BPC-157 safety profile. Animal tolerance data is generally favorable, but robust human safety trials are not available. Here is a balanced summary.
- [BPC-157: what this body protection compound actually is](https://www.halftime.health/learning-center/bpc-157-what-it-is): BPC-157 is a synthetic 15-amino-acid peptide derived from a protein found in gastric juice. Here is what it is in plain English, and why it has attracted so much research interest.
- [Who asks about BPC-157 and what they want to understand](https://www.halftime.health/learning-center/bpc-157-who-asks): Who searches for BPC-157, what they want to understand, and why the U.S. regulatory picture comes first. Plain-English answers without the marketing.
- [When brain fog means 'see a doctor,' not 'try a peptide'](https://www.halftime.health/learning-center/brain-fog-see-doctor-not-peptide): Brain fog is a symptom, not a diagnosis. Here are the common medical causes worth ruling out with a doctor before assuming a peptide is the answer.
- [Caffeine and L-theanine: the well-studied focus stack](https://www.halftime.health/learning-center/caffeine-theanine-focus-stack): Caffeine and L-theanine: a plain-English look at why this pairing is one of the best-studied focus stacks, what the research shows, and the trade-offs.
- [Cognitive testing: how researchers measure "sharper"](https://www.halftime.health/learning-center/cognitive-testing-measure-sharper): How do researchers measure claims that something made you feel "sharper"? Here is how cognitive testing works, and why the details matter most.
- [Cyclic vs linear peptides: why shape changes how they work](https://www.halftime.health/learning-center/cyclic-vs-linear-peptides-why-shape-changes-how-they-work): Cyclic and linear peptides have the same building blocks but different shapes. Here is how a loop versus a strand changes how a peptide works in the body.
- [Cycling peptides: what the research suggests about breaks](https://www.halftime.health/learning-center/cycling-peptides-research): Why do peptide protocols include breaks? Receptor desensitization and tachyphylaxis are real biological phenomena. Here's what the research says about cycling.
- [Disulfide bonds: how peptides hold their shape](https://www.halftime.health/learning-center/disulfide-bonds-peptide-stability): Disulfide bonds are chemical bridges between cysteine residues that lock a peptide into its working shape. Here's how they form and why they matter.
- [Endogenous vs exogenous peptides: natural vs synthetic](https://www.halftime.health/learning-center/endogenous-vs-exogenous-peptides): Endogenous vs exogenous peptides explained in plain English: your body makes some, a lab makes others, and many therapies copy the natural version on purpose.
- [The four peptide families: a practical classification for patients](https://www.halftime.health/learning-center/four-peptide-families-practical-classification): Peptide families explained in plain English: the four practical groups patients ask about — growth, healing, metabolic, and signaling. Not FDA-approved.
- [Glycine: the smallest amino acid, explained](https://www.halftime.health/learning-center/glycine-amino-acid-primer): Glycine is the smallest amino acid and a key building block of collagen. Here's what glycine does, why it matters, and whether it's essential.
- [The growth hormone axis explained: pituitary, GHRH, and IGF-1](https://www.halftime.health/learning-center/growth-hormone-axis-explained): The growth hormone axis explained in plain English: hypothalamus releases GHRH, pituitary releases GH, liver makes IGF-1. The dispatcher–driver–receipt model patients can actually use.
- [How angiogenesis works, and why it matters for healing](https://www.halftime.health/learning-center/how-angiogenesis-works-why-new-blood-vessel-formation-matters-for-tissue-healing): Angiogenesis is how your body grows new blood vessels to heal tissue. Here is what it is, how it works, and why peptide researchers study it, in plain English.
- [How peptides are made: from amino acid to injectable](https://www.halftime.health/learning-center/how-peptides-are-made-synthesis): How peptides are made in plain English: amino acids are linked one at a time on a solid bead, purified, tested, and shipped to a compounding pharmacy.
- [How peptides are different from hormones](https://www.halftime.health/learning-center/how-peptides-differ-from-hormones): Peptides vs hormones in plain English: most hormones are peptides, but the labels describe different things. Here is the clean way to tell them apart.
- [How peptides are different from supplements](https://www.halftime.health/learning-center/how-peptides-differ-from-supplements): Peptides vs supplements in plain English: peptides are prescribed compounds prepared by a pharmacy. Supplements are not. Here is the clean way to tell them apart.
- [How to evaluate any peptide: a framework from evidence-based medicine](https://www.halftime.health/learning-center/how-to-evaluate-any-peptide-a-framework-from-evidence-based-medicine): How to evaluate any peptide: a plain-English framework from evidence-based medicine. Five questions that separate hype from useful research. Educational only.
- [How to talk to your doctor about peptide therapy](https://www.halftime.health/learning-center/how-to-talk-to-doctor-about-peptides): How to bring up peptide therapy with your physician without it feeling awkward. Bring goals, recent labs, and questions — and what to expect back.
- [Humanin: the mitochondrial peptide longevity researchers study](https://www.halftime.health/learning-center/humanin-mitochondrial-derived-peptide): Humanin is a peptide encoded in mitochondrial DNA, studied for its role in cell survival and aging. Here's what it is, how it works, and what research shows.
- [The hydrophobic effect: why peptides fold the way they do](https://www.halftime.health/learning-center/hydrophobic-effect-protein-folding): The hydrophobic effect is water pushing oily molecules together. It is the main force that folds proteins into their working shapes. Here's how.
- [Inflammation: when it heals and when it harms](https://www.halftime.health/learning-center/inflammation-heals-vs-harms): Acute inflammation heals injuries; chronic inflammation quietly harms. Here is the difference between the two and why one is protective and the other is not.
- [Intranasal peptide delivery: what it is and which peptides use it](https://www.halftime.health/learning-center/intranasal-peptide-delivery-explained): Intranasal sprays let small peptides reach the bloodstream and brain without injection. Here is which peptides use this route and the trade-offs.
- [How KPV interacts with melanocortin receptors](https://www.halftime.health/learning-center/kpv-mechanism): KPV is the three-amino-acid tail of alpha-MSH. Animal research links it to anti-inflammatory pathways. Here is what the KPV mechanism actually looks like, in plain English.
- [KPV and the published anti-inflammatory research](https://www.halftime.health/learning-center/kpv-peptide-inflammation): KPV is a tripeptide fragment of alpha-MSH studied in animal models of IBD and colitis. As of 2026, it is Category 2 and not available via 503A compounding pharmacies.
- [KPV: the alpha-MSH fragment and what it is](https://www.halftime.health/learning-center/kpv-what-it-is): KPV is a three-amino-acid fragment of alpha-MSH that has been studied for anti-inflammatory effects, mostly in animal models. Here is what it is, in plain English.
- [Larazotide: the peptide studied for leaky gut, explained](https://www.halftime.health/learning-center/larazotide-tight-junction-celiac): Larazotide is an investigational peptide studied for its role in regulating gut tight junctions. Here's what it is, how it works, and where research stands.
- [Leaky gut: the term, the science, and the overreach](https://www.halftime.health/learning-center/leaky-gut-term-science-overreach): Leaky gut is a real biology term for intestinal permeability, but the wellness version overreaches. Here is what the science supports and what it does not.
- [Why Melatonin Isn't a Sleeping Pill (and What It Actually Does)](https://www.halftime.health/learning-center/melatonin-not-a-sleeping-pill): Is melatonin a sleeping pill? Not exactly. Here's the plain-English difference between a timing signal and a sedative, and why that distinction matters.
- [Frozen Shoulder, Plantar Fasciitis, and Tennis Elbow: Midlife's Common Three](https://www.halftime.health/learning-center/midlife-common-soft-tissue-three): Why do frozen shoulder, plantar fasciitis, and tennis elbow cluster in your 40s and 50s? A look at the shared cause behind midlife soft tissue pain.
- [Native, synthetic, compounded: three words people confuse](https://www.halftime.health/learning-center/native-synthetic-compounded-confusion): Native vs synthetic vs compounded peptide: a plain-English guide to three words people mix up, what each actually means, and why the distinction matters.
- [Off-label prescribing explained: what it means and why it is common](https://www.halftime.health/learning-center/off-label-prescribing-explained): What off-label prescribing is in plain English: it is legal, it is common, and most physicians do it every week. Why peptide protocols often live in this space.
- [Why most peptides can't be pills: the oral delivery problem](https://www.halftime.health/learning-center/oral-peptide-delivery-gut-barrier): Most peptides cannot be pills because the gut destroys them. Here is why oral peptide delivery is so hard and how researchers are solving it.
- [Pentadeca arginate (PDA): the physician-accessible BPC-157 alternative](https://www.halftime.health/learning-center/pentadeca-arginate-pda-the-physician-accessible-bpc-157-alternative): Pentadeca arginate (PDA) is a synthetic analog of BPC-157 that some physicians can access through 503A compounding. Here is what it is and how it differs.
- [Peptide 101: the most-asked beginner questions answered](https://www.halftime.health/learning-center/peptide-101-faqs): Peptide therapy FAQ for beginners. Plain-English answers on how peptides work, who prescribes them, and what to expect. Educational only.
- [Peptide aggregation: why peptides clump together](https://www.halftime.health/learning-center/peptide-aggregation-oligomerization): Peptide aggregation is when peptide molecules clump together instead of staying separate. Here's what it is, why it happens, and why it matters.
- [Why drugmakers modify peptides: analogs explained](https://www.halftime.health/learning-center/peptide-analogs-why-modified): A peptide analog is a modified version of a native peptide, tweaked to last longer or bind better. Here's how analogs work, with CJC-1295 as the example.
- [Peptide-drug conjugates: targeted delivery, explained](https://www.halftime.health/learning-center/peptide-antibody-hybrid-conjugates): A peptide-drug conjugate uses a targeting peptide to deliver a drug directly to diseased cells. Here's how PDCs work and what FDA-approved examples look like.
- [Beta turns: the hairpin bends in a peptide chain](https://www.halftime.health/learning-center/peptide-beta-turns-explained): A beta turn is a tight bend that lets a peptide chain reverse direction in just a few residues. Here's what beta turns are and why they matter for shape.
- [Peptide bonds: the chemical link that holds peptides together](https://www.halftime.health/learning-center/peptide-bonds-the-chemical-link-that-holds-peptides-together): A peptide bond is the chemical clasp that joins amino acids into a chain. Here is what it is, how it forms, and why it decides how peptides behave.
- [C-terminal amidation: the finishing touch on many peptides](https://www.halftime.health/learning-center/peptide-c-terminal-amidation): C-terminal amidation is a final tweak to a peptide's tail end. Here is how it changes the molecule and why about half of active peptides have it.
- [Peptide denaturation: what makes a peptide lose its shape](https://www.halftime.health/learning-center/peptide-denaturation-explained): Peptide denaturation means losing the 3D shape a peptide needs to work. Learn what causes it, whether it's reversible, and why storage matters.
- [Peptide depot formulations explained simply](https://www.halftime.health/learning-center/peptide-depot-formulations-explained): A peptide depot formulation traps the drug in tiny beads so it releases over weeks or months. Here is what a depot injection is and how it works.
- [How peptide dosing differs from conventional drug dosing](https://www.halftime.health/learning-center/peptide-dosing-basics): Peptide dosing is measured in micrograms, not milligrams, and timed to body rhythms. Here is why the units, timing, and route differ from a typical pill.
- [Peptide glycosylation: sugars attached to peptides](https://www.halftime.health/learning-center/peptide-glycosylation-explained): Peptide glycosylation is the attachment of sugar chains to a peptide. Here's what N-linked and O-linked mean, why it matters, and how it changes function.
- [Peptide half-life basics: why dosing schedules vary](https://www.halftime.health/learning-center/peptide-half-life-basics): Why do some peptides require daily injections while others work weekly? The answer is half-life. Here's a plain-English explanation of peptide pharmacokinetics.
- [Peptide half-life: how long peptides last in the body](https://www.halftime.health/learning-center/peptide-half-life-clearance): Peptide half-life is how long a peptide lasts in the body before half is cleared. Here is why most peptides act fast, clear fast, and why that shapes dosing.
- [Peptide half-life: why some need daily shots and others don't](https://www.halftime.health/learning-center/peptide-half-life-why-some-need-daily-shots-and-others-dont): Half-life is how fast your body clears a peptide. It explains why some peptides need daily shots and others last for days. Here is the plain-English version.
- [Peptide hydration shell: the water layer around peptides](https://www.halftime.health/learning-center/peptide-hydration-shell): A peptide hydration shell is the ordered layer of water that surrounds a peptide. Here's how it forms and why it shapes a peptide's folding and function.
- [Isoelectric point: why some peptides are hard to dissolve](https://www.halftime.health/learning-center/peptide-isoelectric-point-solubility): A peptide dissolves worst at its isoelectric point, the pH where its net charge is zero. Here is what that means for mixing and storing peptides.
- [What happens to a peptide after you inject it](https://www.halftime.health/learning-center/peptide-metabolism-after-injection): After you inject a peptide, it enters the blood, binds its receptors, then enzymes cut it into amino acids. Here's the journey — and why it matters.
- [Peptide molecular weight: what daltons mean](https://www.halftime.health/learning-center/peptide-molecular-weight-daltons): Peptide molecular weight is the total mass of a peptide, measured in daltons. Here's what a dalton is, why kDa is used, and how to estimate mass.
- [N-terminal acetylation: a common peptide tag](https://www.halftime.health/learning-center/peptide-n-terminal-acetylation): N-terminal acetylation is a common chemical tag added to the front of a protein. Here's what it is, what it does, and why it matters for peptides.
- [Peptide names decoded: reading CJC-1295, GHRP-6, and more](https://www.halftime.health/learning-center/peptide-naming-conventions-explained): Peptide names like CJC-1295 and GHRP-6 follow a pattern. Here is how to read the acronyms, discovery codes, and analog suffixes in any peptide name.
- [Peptide net charge: why peptides carry a charge](https://www.halftime.health/learning-center/peptide-net-charge-explained): A peptide's net charge is the sum of its positive and negative charges at a given pH. Here's what gives a peptide its charge and why it matters.
- [PEGylation: attaching PEG to make peptides last longer](https://www.halftime.health/learning-center/peptide-pegylation-explained): PEGylation attaches polyethylene glycol chains to a peptide to slow how fast the body clears it. Here's what PEGylation is and why drug makers use it.
- [Peptide PhDs: how academic research is catching up to the clinic](https://www.halftime.health/learning-center/peptide-phds-how-academic-research-is-catching-up-to-clinical-peptide-use): Clinical peptide use has outrun the published evidence in many cases. Here's how academic research is catching up, and why the gap matters, in plain English.
- [Peptide phosphorylation explained in plain English](https://www.halftime.health/learning-center/peptide-phosphorylation-explained): Peptide phosphorylation is the body adding a phosphate tag to switch a protein on or off. Here is what it is, how it works, and why it matters.
- [Peptide purity and the certificate of analysis: how to read a COA](https://www.halftime.health/learning-center/peptide-purity-reading-coa): A certificate of analysis tells you what is actually in a peptide vial. Here is how to read one, what to look for, and where COAs fall short.
- [How peptides act on receptors: the key and lock explained](https://www.halftime.health/learning-center/peptide-receptor-mechanism): How peptides interact with cell-surface receptors in plain English — the key-and-lock model, conformational change, the cascade that follows, and why specificity matters.
- [Peptide receptor selectivity: why some peptides are more targeted](https://www.halftime.health/learning-center/peptide-receptor-selectivity-why-some-peptides-are-more-targeted): Why do some peptides act like a precise key and others hit many locks? Receptor selectivity explains targeting and side effects, in plain English.
- [Peptide risks and contraindications: what everyone should know](https://www.halftime.health/learning-center/peptide-risks-overview): Peptide therapy risks and contraindications, in plain English. Who should not use peptides, common side effects, and the safety floor. Educational only.
- [Who is searching for information about peptides and why](https://www.halftime.health/learning-center/peptide-searchers-intent): Who is researching peptide therapy in 2026 and what they want to know — the search patterns behind the most common questions and the contexts that drive them.
- [Peptide secondary structure: the helix and the sheet](https://www.halftime.health/learning-center/peptide-secondary-structure-helix-sheet): Peptide secondary structure is the local folding of the chain into alpha helices and beta sheets. Here is how hydrogen bonds give a peptide its shape.
- [Peptide stacking 101: principles for safe combinations](https://www.halftime.health/learning-center/peptide-stacking-101-principles): Peptide stacking means combining peptides that work on different pathways. Here are the principles clinicians use and the mistakes to avoid.
- [Peptide synergism: how clinicians think about combination protocols](https://www.halftime.health/learning-center/peptide-synergism-how-clinicians-think-about-combination-protocols): Peptide combinations explained: how clinicians think about pairing peptides, where the evidence is strongest, and why more is not always better. Educational.
- [Peptide tertiary and quaternary structure, explained](https://www.halftime.health/learning-center/peptide-tertiary-quaternary-structure): Tertiary structure is a protein's full 3D fold. Quaternary structure is two or more folded chains assembled together. Here's what that means.
- [Peptide therapy research: how the field has evolved since 1921](https://www.halftime.health/learning-center/peptide-therapy-research-history): Peptide medicine began in 1921 with insulin. A century later, 100+ peptide drugs are on the market. Here's the short history of how the field got here.
- [Peptides 101: 10 questions first-time patients ask](https://www.halftime.health/learning-center/peptides-101-ten-common-questions): Ten plain-English answers to the most common questions first-time patients ask about peptide therapy — what they are, how they work, and what to ask a clinician.
- [Peptides and the blood-brain barrier explained](https://www.halftime.health/learning-center/peptides-and-the-blood-brain-barrier): The blood-brain barrier blocks most peptides from reaching the brain. Here is what the barrier is, why it stops peptides, and how a few get through.
- [How to have a goals-first conversation with your clinician](https://www.halftime.health/learning-center/peptides-and-your-clinician): Before naming a compound, start with what you actually want. Here's how to structure a productive goals-first conversation with a clinician about peptide options.
- [Peptides and cancer history: why the IGF-1 question matters](https://www.halftime.health/learning-center/peptides-cancer-igf1-question): Some peptides raise IGF-1, a growth signal. Here is why a personal or family cancer history changes the peptide conversation, explained in plain English.
- [Peptides vs hormones: the overlap and the distinction](https://www.halftime.health/learning-center/peptides-vs-hormones): Every peptide is not a hormone, and every hormone is not a peptide. Here's a plain-English map of where the two overlap and where they diverge.
- [Peptides vs small-molecule drugs: keys vs hammers](https://www.halftime.health/learning-center/peptides-vs-small-molecules): Peptides bind to specific receptors like a key in a lock. Small-molecule drugs work differently. Here's what that distinction means for how each interacts with your body.
- [Probiotics, Prebiotics, and Postbiotics: What Actually Separates Them](https://www.halftime.health/learning-center/probiotics-prebiotics-postbiotics-differences): What is the difference between probiotics and prebiotics? A plain-English guide to all three gut-health terms, backed by the real scientific definitions.
- [Proline and cis-trans isomerization in peptides](https://www.halftime.health/learning-center/proline-cis-trans-isomerization): Proline cis-trans isomerization is a slow flip in the peptide bond before proline. Here's what it is, why proline is unusual, and how enzymes speed it up.
- [PRP, prolotherapy, and where peptides sit in regenerative care](https://www.halftime.health/learning-center/prp-prolotherapy-peptides-landscape): Regenerative care spans PRP, prolotherapy, and peptides — three different materials with different FDA rules and very different levels of human evidence.
- [Racemization and D-amino acids: why peptide chirality matters](https://www.halftime.health/learning-center/racemization-and-d-amino-acids): D-amino acids are mirror-image building blocks that help peptides resist breakdown. Here is how chirality works and why drug designers use them.
- [Receptor specificity: why peptides are more targeted than small-molecule drugs](https://www.halftime.health/learning-center/receptor-specificity-peptides-targeted): Peptides are more receptor-specific than most small-molecule drugs. Here is what that means in plain English — and why specificity is not risk-free.
- [Salt bridges: the electrostatic links that shape peptides](https://www.halftime.health/learning-center/salt-bridge-electrostatic-peptides): A salt bridge is an attraction between two oppositely charged parts of a peptide. Here is how these electrostatic links help shape and stabilize it.
- [Semax: the nootropic peptide, explained](https://www.halftime.health/learning-center/semax-nootropic-peptide-explained): Semax is a synthetic peptide from an ACTH fragment, studied in Russia for focus. Here's what it is, how it works, and its US regulatory status.
- [Short-chain fatty acids: how gut bacteria talk to immunity](https://www.halftime.health/learning-center/short-chain-fatty-acids-immune): Short-chain fatty acids are the messengers gut bacteria make from fiber. Here is how butyrate and its cousins help calm and coordinate the immune system.
- [Soft-tissue healing timelines: what biology allows](https://www.halftime.health/learning-center/soft-tissue-healing-timelines): Soft-tissue healing follows three phases and can take weeks to a year. Here is why tendons and ligaments heal slowly and what the biology actually allows.
- [How TB-500 works: actin regulation and tissue signaling](https://www.halftime.health/learning-center/tb-500-mechanism): TB-500's proposed mechanisms center on actin sequestration, cell migration, anti-inflammatory signaling, and angiogenesis. Here is what the preclinical research actually shows.
- [TB-500 research: what the literature shows](https://www.halftime.health/learning-center/tb-500-research): An honest summary of the TB-500 and Thymosin Beta-4 research landscape: where the evidence is strong, where it is limited, and what the open questions are.
- [TB-500 side effects and what the literature reports](https://www.halftime.health/learning-center/tb-500-side-effects): TB-500 side effects in plain English — what the published literature reports, what is rare versus common, and the long-term human safety data gap that should slow anyone down.
- [TB-500: what Thymosin Beta-4 is and why it matters](https://www.halftime.health/learning-center/tb-500-what-it-is): TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein found in nearly every cell of the body. Here is what it is, how it differs from full Thymosin Beta-4, and why it matters.
- [Who asks about TB-500 and the questions they bring](https://www.halftime.health/learning-center/tb-500-who-asks): Who asks about TB-500, what they want to understand, and where U.S. access stands in 2026. Plain-English answers grounded in the published literature.
- [Why longevity researchers avoid 'age-reversal' language — and what they use instead](https://www.halftime.health/learning-center/the-fountain-of-youth-framing-why-longevity-researchers-use-different-language): Words like 'reverse aging' and 'age-reversal' are everywhere in wellness marketing. Longevity researchers almost never use them. Here's why — and what they say instead.
- [The four peptide families: a practical classification for patients](https://www.halftime.health/learning-center/the-four-peptide-families-a-practical-classification-for-patients): There are dozens of named peptides — but only four practical families to know. Here is a plain-English map so the rest of the field makes sense.
- [The stack mentality: why more peptides aren't always better](https://www.halftime.health/learning-center/the-stack-mentality-why-more-peptides-dont-always-mean-better-results): Adding more peptides to a protocol isn't the same as getting better results. Here's what the research and clinical practice actually say, in plain English.
- [What are peptides? A plain-English primer](https://www.halftime.health/learning-center/what-are-peptides): Peptides are short chains of amino acids your body already makes. Learn what they are, how they differ from proteins, and why they matter for health research.
- [What happens at a peptide telehealth consultation](https://www.halftime.health/learning-center/what-happens-peptide-telehealth-consult): A plain-English walkthrough of a peptide telehealth visit: what the clinician asks, what labs you may need, and how a prescription gets compounded and shipped.
- [What is a peptide: a plain-English primer](https://www.halftime.health/learning-center/what-is-a-peptide): A peptide is a short chain of amino acids — bigger than a single amino acid, smaller than a protein. Here is what that means, in plain English.
- [What is an amino acid? The building block behind every peptide](https://www.halftime.health/learning-center/what-is-an-amino-acid-the-building-block-behind-every-peptide): Amino acids are the building blocks that link together to form every peptide and protein. Here is what they are and how they make peptides work.
- [What is bacteriostatic water, and why peptides are mixed with it](https://www.halftime.health/learning-center/what-is-bacteriostatic-water-and-why-peptides-are-mixed-with-it): Bacteriostatic water is the liquid used to mix many peptides. Here is what benzyl alcohol does, how it differs from sterile water, and why it matters.
- [Local vs systemic peptide action in injury recovery](https://www.halftime.health/learning-center/what-local-vs-systemic-peptide-action-means-for-injury-recovery): Some peptides act mainly where injected; others travel body-wide. Here is what local vs systemic action means for injury recovery, in plain English.
- [What makes a peptide different from a protein?](https://www.halftime.health/learning-center/what-makes-a-peptide-different-from-a-protein): Peptides and proteins are built from the same parts, so what's the difference? It mostly comes down to size. Here's the plain-English explanation.
- [What to look for in a physician who prescribes peptides](https://www.halftime.health/learning-center/what-to-look-for-in-a-physician-who-prescribes-peptides): A practical checklist for evaluating a physician or telehealth service that prescribes peptides — credentials, labs, follow-up, and a few red flags.
- [Who should not use peptides: clinical contraindications](https://www.halftime.health/learning-center/who-should-not-use-peptides): Some people should not use peptide therapy. Here are the published contraindications clinicians screen for — pregnancy, cancer, and unstable illness.
- [Why animal studies don't prove human outcomes](https://www.halftime.health/learning-center/why-animal-studies-dont-prove-human-outcomes-a-primer-for-peptide-patients): Most peptide research starts in mice, not people. Here is why a result in animals does not promise the same result in humans, in plain English.
- [Why peptides come as acetate salts, explained](https://www.halftime.health/learning-center/why-peptides-are-acetate-salts): Many peptides are made as acetate salts. Here's what a salt form means, why acetate is preferred over trifluoroacetate, and what it means for you.
- [Why peptides come as a freeze-dried powder: lyophilization explained](https://www.halftime.health/learning-center/why-peptides-come-as-a-freeze-dried-powder-lyophilization-explained): Why do peptides arrive as a dry powder instead of a ready liquid? The answer is lyophilization, or freeze-drying. Here is how it works and why it protects them.
- [Why peptides are dosed in micrograms, not milligrams](https://www.halftime.health/learning-center/why-peptides-dosed-micrograms): Peptides work at the receptor level, so doses are measured in micrograms — millionths of a gram. Here's why tiny doses make sense and why precision matters.
- [Why YouTube peptide dosing differs from physician protocols](https://www.halftime.health/learning-center/why-youtube-peptide-dosing-advice-differs-from-physician-protocols): Online peptide doses and clinic protocols often disagree. Here is why that gap exists, in plain English, and which one is built around your safety.

## Men's Health
- [CJC-1295 with DAC vs without DAC: which form and why](https://www.halftime.health/learning-center/cjc-1295-dac-vs-no-dac-comparison): CJC-1295 comes in two forms — with DAC and without. Plain-English breakdown of how each one signals growth hormone, and why clinicians pick one over the other.
- [CJC-1295 + Ipamorelin: why they are often combined](https://www.halftime.health/learning-center/cjc-1295-ipamorelin-combo): CJC-1295 and ipamorelin stimulate growth hormone through different receptors. Combined, they produce a synergistic GH pulse without raising cortisol or prolactin.
- [Why physicians combine CJC-1295 and ipamorelin (and not just one)](https://www.halftime.health/learning-center/cjc-1295-ipamorelin-why-they-work-together): Why clinicians pair CJC-1295 with ipamorelin to amplify the body's natural growth hormone pulse, in plain English. Compounded peptides not FDA-approved.
- [How CJC-1295 extends GHRH signaling: the mechanism](https://www.halftime.health/learning-center/cjc-1295-mechanism): CJC-1295 is a modified GHRH analog with extended half-life. Here is how the mechanism works in plain English — and what makes it different from sermorelin.
- [CJC-1295 research: what the published literature reports](https://www.halftime.health/learning-center/cjc-1295-research): CJC-1295 research summary — what the published trials show about IGF-1, growth hormone pulses, and side effects. Compounded CJC-1295 is not FDA-approved.
- [CJC-1295: separating the mechanism from the hype](https://www.halftime.health/learning-center/cjc-1295-separating-the-mechanism-from-the-hype): CJC-1295 is widely discussed and widely misunderstood. Here is what the peptide actually does, what it does not do, and what the literature supports.
- [CJC-1295 side effects: what the literature reports](https://www.halftime.health/learning-center/cjc-1295-side-effects): CJC-1295 side effects in plain English — what the published literature reports, common reactions, and what should prompt a clinician call promptly.
- [CJC-1295 vs sermorelin: comparing two GHRH analogs](https://www.halftime.health/learning-center/cjc-1295-vs-sermorelin): CJC-1295 vs sermorelin, explained. How two GHRH analogs differ in half-life, dosing frequency, and clinical positioning — without the broscience. Educational only.
- [CJC-1295: what this modified GHRH peptide is](https://www.halftime.health/learning-center/cjc-1295-what-it-is): CJC-1295 is a modified GHRH peptide. Here is what it is in plain English: what the molecule looks like, why DAC matters, and how it differs from sermorelin.
- [Who asks about CJC-1295 and what they want to know](https://www.halftime.health/learning-center/cjc-1295-who-asks): Who asks about CJC-1295, what they are trying to understand, and how this growth hormone secretagogue is typically used in clinical peptide protocols.
- [The classic peptide combination: why CJC-1295 and ipamorelin work better together](https://www.halftime.health/learning-center/cjc-ipamorelin-why-they-work-together): CJC-1295 and ipamorelin are usually prescribed together. Here is why two peptides do something one cannot do alone — explained in plain English.
- [Enclomiphene vs peptides vs TRT: a decision map for men](https://www.halftime.health/learning-center/enclomiphene-vs-peptides-vs-trt-decision): Enclomiphene, peptide secretagogues, and TRT each take a different route to address low testosterone. Here is a plain-English decision map for men in midlife.
- [Fatigue in men over 40: a hormonal and metabolic map](https://www.halftime.health/learning-center/fatigue-men-over-40-hormonal-map): Fatigue in men over 40 is rarely one thing. Here is a plain-English map of the hormonal, metabolic, and lifestyle drivers a clinician will work through.
- [Free vs total testosterone: what the two numbers actually mean](https://www.halftime.health/learning-center/free-vs-total-testosterone-what-the-two-numbers-actually-mean): A testosterone test often shows two numbers. Here is what free vs total testosterone means, why both matter, and how to read them in plain English.
- [GH peptides and body recomposition: what to actually expect](https://www.halftime.health/learning-center/gh-peptides-body-recomposition-expectations): Growth hormone peptides like sermorelin and CJC-1295/ipamorelin are studied for body composition. What the published data shows — and the realistic timelines.
- [Growth hormone peptides and sleep architecture: the research](https://www.halftime.health/learning-center/gh-peptides-sleep-architecture-research): Growth hormone peptides and sleep in plain English: most natural GH release happens in deep sleep, and peptide therapies aim to support that same window.
- [GH peptides and VO2max: what the aerobic-capacity research shows](https://www.halftime.health/learning-center/gh-peptides-vo2max-aerobic-capacity-research): Growth-hormone peptides are studied mostly for body composition. The aerobic-capacity data is thinner. Here is what published research shows about VO2max.
- [Growth hormone secretagogues vs exogenous HGH: why the distinction matters](https://www.halftime.health/learning-center/growth-hormone-secretagogues-vs-exogenous-hgh-why-the-distinction-matters): Exogenous HGH adds growth hormone directly. Secretagogues ask your pituitary to make more. That difference in mechanism has meaningful safety and regulatory implications.
- [The HPA-HPG axis: how stress fights testosterone](https://www.halftime.health/learning-center/hpa-hpg-axis-stress-testosterone): Chronic stress can lower testosterone for biological reasons, not psychological ones. Here is the brain-to-testes wiring, in plain English.
- [Insulin resistance and male fertility: how metabolic health affects sperm quality](https://www.halftime.health/learning-center/insulin-resistance-and-male-fertility-how-metabolic-health-affects-sperm-quality): Insulin resistance doesn't just affect blood sugar — research links it to lower testosterone and reduced sperm quality in men. Here's what the literature shows.
- [Ipamorelin cortisol profile: why it is preferred over GHRP-2 and GHRP-6](https://www.halftime.health/learning-center/ipamorelin-cortisol-profile-why-it-is-preferred-over-ghrp-2-and-ghrp-6): GHRP-2 and GHRP-6 raise growth hormone — but they also raise cortisol and prolactin. Ipamorelin does not. Here is why that selectivity matters in practice.
- [Ipamorelin FAQ: the questions clinicians hear most](https://www.halftime.health/learning-center/ipamorelin-faqs): Ipamorelin FAQ in plain English: timing, side effects, sleep, hunger, and combination questions — answered with citations and a clinician's posture.
- [How ipamorelin triggers growth hormone secretion](https://www.halftime.health/learning-center/ipamorelin-mechanism): How ipamorelin works in plain English: a selective ghrelin-receptor mimic that prompts a clean GH pulse without spiking cortisol or prolactin like older GHRPs.
- [Ipamorelin research: published evidence reviewed](https://www.halftime.health/learning-center/ipamorelin-research): Ipamorelin is a selective growth hormone secretagogue with a well-described animal record and a smaller human one. Here is what the ipamorelin research base actually shows.
- [Ipamorelin: the selective GH secretagogue with the cleanest profile](https://www.halftime.health/learning-center/ipamorelin-selective-clean-gh-peptide): Ipamorelin in plain English: a short peptide that nudges the pituitary to release growth hormone without spiking cortisol or hunger. Here is what the research actually shows.
- [Ipamorelin side effects: what the literature reports](https://www.halftime.health/learning-center/ipamorelin-side-effects): Ipamorelin is among the cleanest GHRPs in the literature, but it is not side-effect free. Here is what the published trials and case reports actually describe.
- [Ipamorelin: what this GHRP peptide is](https://www.halftime.health/learning-center/ipamorelin-what-it-is): Ipamorelin is a five-amino-acid synthetic peptide in the GHRP family that signals the pituitary to release growth hormone. Here is what it is, in plain English.
- [Who asks about ipamorelin and what they are looking for](https://www.halftime.health/learning-center/ipamorelin-who-asks): People searching for ipamorelin usually have specific questions about growth hormone, body composition, and aging. Here is who asks and what they want to know.
- [Who asks about kisspeptin-10, and the questions behind it](https://www.halftime.health/learning-center/kisspeptin-10-who-asks): Kisspeptin-10 sits at the top of the reproductive hormone chain. Investigational, not FDA-approved. See what questions people bring and what the research shows.
- [Male fertility decline: what the published data shows](https://www.halftime.health/learning-center/male-fertility-decline): Global sperm counts have dropped roughly in half over five decades — and the decline is steepest in men born after 2000. Here's what the data shows.
- [Male fertility and insulin resistance: the literature link](https://www.halftime.health/learning-center/male-fertility-insulin-resistance): Insulin resistance is associated with lower testosterone and changes in sperm parameters. Here's what the peer-reviewed literature says about the link.
- [Who asks about male fertility and what they want to understand](https://www.halftime.health/learning-center/male-fertility-who-asks): Who searches for male fertility treatment, what the CDC and WHO data show about infertility rates, and how hormones like FSH, LH, and testosterone affect sperm.
- [How MK-677 stimulates growth hormone: the ghrelin pathway](https://www.halftime.health/learning-center/mk-677-mechanism): MK-677 mechanism explained: ibutamoren mimics the body's hunger hormone ghrelin to push the pituitary into releasing growth hormone. Here is how.
- [MK-677 (Ibutamoren): an oral growth-hormone secretagogue](https://www.halftime.health/learning-center/mk-677-oral-secretagogue): MK-677 is an oral ghrelin-receptor agonist studied for raising IGF-1 in adults. Here's what the published research actually shows.
- [MK-677 explained: what an oral growth hormone secretagogue actually does](https://www.halftime.health/learning-center/mk-677-oral-secretagogue-deep-dive): MK-677 is an oral compound that mimics ghrelin to raise growth hormone and IGF-1. Here is what the research shows, and the tradeoffs to monitor.
- [MK-677 research: what the published trials report](https://www.halftime.health/learning-center/mk-677-research): MK-677 research summary — what the published trials show about IGF-1, body composition, sleep, and side effects. MK-677 is not FDA-approved as a therapy.
- [MK-677 side effects: water retention, insulin, appetite, and more](https://www.halftime.health/learning-center/mk-677-side-effects): MK-677 side effects in plain English: water retention, blood-sugar shifts, appetite changes, and what the published clinical trials describe. Not FDA-approved.
- [Who asks about MK-677, and what they want to know](https://www.halftime.health/learning-center/mk-677-who-asks): MK-677 (ibutamoren) is an oral compound studied for growth hormone support. Not FDA-approved. Learn what questions people bring and what the research says.
- [Muscle mass after 40: why building gets harder and what helps](https://www.halftime.health/learning-center/muscle-mass-after-40-anabolic-window): Building muscle gets harder in your 40s — here's the biology of why, and what training, protein, and physician-supervised peptides can support.
- [Peptide recovery after injury: what the published evidence supports](https://www.halftime.health/learning-center/peptide-recovery-after-injury-prime-overview): Recovery peptides like BPC-157 and TB-500 are mostly animal-data heavy and currently Category 2. Here is what the published literature supports and what it does not.
- [Peptides and bone density: what the literature actually shows](https://www.halftime.health/learning-center/peptides-bone-density-literature): Peptides and bone density — a careful read of the human evidence, where it holds up, and where it stops short of supporting bone-loss prevention claims.
- [Peptides and male fertility: what the literature actually links](https://www.halftime.health/learning-center/peptides-male-fertility-literature): Peptides and male fertility in plain English: what the published literature actually links between metabolic health, growth hormone peptides, and sperm parameters.
- [Peptides for men in midlife: a framework for starting smart](https://www.halftime.health/learning-center/peptides-men-midlife-starting-framework): Peptides for men in midlife: a plain-English framework. Start with goals, run a baseline blood panel, pick one well-studied peptide, and measure. Why fewer changes beat more changes.
- [Sarcopenia prevention: what every man over 50 should know](https://www.halftime.health/learning-center/sarcopenia-prevention-men-over-50): Sarcopenia is the slow muscle loss that quietly steals strength after 50. Here's how resistance training, protein intake, and lab tracking prevent it.
- [Is sermorelin a better choice than HGH in midlife? What the case actually looks like](https://www.halftime.health/learning-center/sermorelin-better-than-hgh-men-over-40): Sermorelin vs HGH in midlife: how each works, what the research shows, and the trade-offs. Compounded sermorelin is not FDA-approved.
- [Sermorelin, CJC-1295, ipamorelin, MK-677: a plain-language comparison](https://www.halftime.health/learning-center/sermorelin-cjc-1295-ipamorelin-mk-677-a-plain-language-comparison): Sermorelin, CJC-1295, ipamorelin, MK-677: four growth hormone peptides, four different jobs. Plain-English comparison of how each one signals the pituitary.
- [Sermorelin explained: the GHRH analog](https://www.halftime.health/learning-center/sermorelin-explained): Sermorelin is a 29-amino-acid GHRH analog that stimulates the pituitary to release growth hormone. Here's how it works, what the research says, and what to know.
- [Sermorelin FAQ: the top questions answered](https://www.halftime.health/learning-center/sermorelin-faqs): Sermorelin FAQ — what it is, how it works, who it is for, side effects, and regulatory status. Plain-English answers to the most common sermorelin questions.
- [How sermorelin signals growth hormone release](https://www.halftime.health/learning-center/sermorelin-mechanism): How does sermorelin actually trigger growth hormone? A plain-English walk through the GHRH receptor, the pituitary, and the pulse the body still controls.
- [What the published research says about sermorelin](https://www.halftime.health/learning-center/sermorelin-research-summary): A plain-English summary of the published sermorelin research — pediatric trials, adult off-label data, IGF-1 response, sleep architecture, and the limits of the evidence.
- [Sermorelin side effects: what the literature reports](https://www.halftime.health/learning-center/sermorelin-side-effects): Sermorelin side effects in trials are usually mild and short-lived: injection-site reactions, brief flushing, occasional headache. Here is what to flag.
- [Sermorelin and sleep: what the data shows](https://www.halftime.health/learning-center/sermorelin-sleep-huberman-data): Sermorelin and sleep in plain English: a GHRH analog dosed at night may support deeper sleep, but the published data is mixed and individual response varies.
- [Sermorelin vs CJC-1295: how the two GHRH analogs differ](https://www.halftime.health/learning-center/sermorelin-vs-cjc-1295): Sermorelin vs CJC-1295 in plain English: half-life, dosing, side-effect profile, and how clinicians decide between two GHRH analogs in a GH-peptide protocol.
- [Sermorelin vs HGH: a GHRH analog vs the hormone itself](https://www.halftime.health/learning-center/sermorelin-vs-hgh-clinical-difference): Sermorelin vs HGH in plain English: one prompts your pituitary to release its own growth hormone; the other pours it in from outside. Here is why that matters.
- [Sermorelin vs tesamorelin: different compounds, different data](https://www.halftime.health/learning-center/sermorelin-vs-tesamorelin): Sermorelin and tesamorelin are both GHRH analogs, but they behave differently. Here is how they compare on half-life, FDA status, and study population.
- [Sermorelin explained: the GHRH analog primer](https://www.halftime.health/learning-center/sermorelin-what-it-is): Sermorelin is a 29-amino-acid peptide that nudges your own pituitary to release growth hormone — a slower, more physiologic alternative to direct HGH injection.
- [Who asks about sermorelin and what they are trying to understand](https://www.halftime.health/learning-center/sermorelin-who-asks): Who asks about sermorelin, what they are trying to understand, and what the clinical picture actually looks like for this growth hormone secretagogue.
- [Sleep deprivation and hormone disruption: why recovery is non-negotiable](https://www.halftime.health/learning-center/sleep-deprivation-hormone-disruption): How short sleep disrupts testosterone, cortisol, and growth hormone signaling in plain English — and why recovery is the cheapest performance lever in midlife.
- [Tesamorelin: from HIV lipodystrophy to off-label visceral fat research](https://www.halftime.health/learning-center/tesamorelin-from-hiv-lipodystrophy-to-off-label-visceral-fat-research): Tesamorelin is the only GHRH analog with an FDA indication — for HIV-related fat changes. Here's how it moved from that approval into longevity research.
- [How tesamorelin targets visceral fat: the mechanism](https://www.halftime.health/learning-center/tesamorelin-mechanism): How tesamorelin works, in plain English: a stabilized GHRH analog that signals the pituitary for more growth hormone, with a measured effect on visceral fat.
- [Tesamorelin: the FDA-approved GHRH analog explained](https://www.halftime.health/learning-center/tesamorelin-what-it-is): Tesamorelin (Egrifta) is FDA-approved for one HIV-related indication while the compounded version is not FDA-approved. Here is the plain-English primer on this GHRH analog.
- [Who asks about tesamorelin and what they want to understand](https://www.halftime.health/learning-center/tesamorelin-who-asks): People searching for tesamorelin are usually researching visceral fat and GHRH. Here is who asks, what they want to know, and what research shows.
- [Testosterone vs peptide secretagogues: how they differ](https://www.halftime.health/learning-center/testosterone-vs-peptides): TRT replaces testosterone directly. GH secretagogues like sermorelin work upstream. They have different mechanisms, endpoints, and trade-offs.
- [Thymosin alpha-1 and the immune system](https://www.halftime.health/learning-center/thymosin-alpha-1-immune): Thymosin alpha-1 is a 28-amino-acid peptide derived from prothymosin-alpha that modulates T-cell maturation. Here's what the published research says.
- [Thymosin alpha-1 and immune aging: the T-cell research](https://www.halftime.health/learning-center/thymosin-alpha-1-immune-aging): Thymosin alpha-1 is studied for immune aging. Here is what the T-cell research shows, how Zadaxin is used abroad, and how to read the evidence. Not US-approved.
- [Thymosin alpha-1 and infection resistance: what the studies show](https://www.halftime.health/learning-center/thymosin-alpha-1-infection-resistance): Thymosin alpha-1 has been studied in sepsis, hepatitis B, and severe COVID-19. Here is what the trial data actually showed and where the strongest signals are.
- [How thymosin alpha-1 signals the immune system: the mechanism](https://www.halftime.health/learning-center/thymosin-alpha-1-mechanism): Thymosin alpha-1 mechanism in plain English: a 28-amino-acid peptide from the thymus that activates toll-like receptors to nudge T cells and dendritic cells toward action.
- [Thyroid and growth hormone peptides: the metabolic overlap](https://www.halftime.health/learning-center/thyroid-growth-hormone-peptides-overlap): Thyroid and growth hormone peptides overlap in metabolism and lab work. What the published evidence shows and why both panels matter. Educational only.
- [TRT vs peptide secretagogues: two different philosophies](https://www.halftime.health/learning-center/trt-vs-peptide-secretagogues-philosophy): TRT replaces a hormone. Peptide secretagogues nudge the body to make more of its own. A plain-English breakdown of the two philosophies and when each makes sense.
- [Who asks about ipamorelin, and why](https://www.halftime.health/learning-center/who-asks-about-ipamorelin-and-why): Who searches for ipamorelin and what are they hoping it does? Here is the honest picture of the questions people bring to this growth-hormone peptide.

## Labs
- [A1C and fasting glucose: the two metabolic baselines](https://www.halftime.health/learning-center/a1c-fasting-glucose): A1C and fasting glucose measure different things about blood sugar. Here's how they work, what the ADA thresholds mean, and why both are relevant before a GLP-1 protocol.
- [Advanced Lipid Panel FAQ: Cost, Fasting, and How Often to Test](https://www.halftime.health/learning-center/advanced-lipid-faqs): Advanced lipid panel FAQ: what it costs, whether you need to fast, if insurance covers it, and how often to get one. Practical answers before you book a test.
- [Albumin: what this blood protein reveals about your health](https://www.halftime.health/learning-center/albumin-blood-marker): An albumin blood test measures a key liver protein that keeps fluid in your vessels. Here is what high and low albumin can signal about your health.
- [ApoB vs LDL: which lab better predicts cardiovascular risk](https://www.halftime.health/learning-center/apob-vs-ldl-cardiovascular-risk): ApoB vs LDL — what each lab counts, why ApoB has emerged as a sharper predictor of cardiovascular risk, and what to ask your clinician about the test.
- [ApoB explained: the advanced lipid marker clinicians track](https://www.halftime.health/learning-center/apob-what-it-is): ApoB counts the particles that actually carry cholesterol into artery walls. Here is what the marker measures, why it matters, and how it compares to LDL.
- [At-Home Health Testing in 2026: What's Reliable and What's Not](https://www.halftime.health/learning-center/at-home-testing-2026-reliable): Are at-home blood tests accurate? Some biomarkers hold up to finger-prick testing well; others don't. Here's a plain-English guide to which is which.
- [The baseline blood panel: what to test before any peptide protocol](https://www.halftime.health/learning-center/baseline-blood-panel-before-protocol): The baseline blood panel before peptide therapy in plain English: CMP, lipid panel, A1C, fasting insulin, IGF-1, testosterone, hs-CRP. Why a starting number is the only way to measure change.
- [Biomarkers commonly tracked during peptide protocols](https://www.halftime.health/learning-center/biomarkers-for-peptide-protocols): A practical overview of the lab panels clinicians commonly order before and during peptide protocols — including IGF-1, A1C, CMP, lipids, and hormone markers.
- [Why bloodwork is the foundation of every peptide protocol](https://www.halftime.health/learning-center/biomarkers-foundation): Baseline bloodwork is the unphotogenic part of peptide therapy — and the part that matters most. Here's what a foundation panel covers and why it comes first.
- [What Bloodwork Cannot Tell You: The Limits of Lab Panels](https://www.halftime.health/learning-center/biomarkers-limits): Bloodwork cannot tell you everything: reference ranges include most healthy people by design, single draws miss variation, and normal labs can hide problems.
- [How biomarker panels actually work: what a blood test is doing](https://www.halftime.health/learning-center/biomarkers-mechanism): A biomarker panel measures specific molecules in your blood. Here is how the lab actually does it, why reference ranges differ, and what a result really tells you.
- [Who should get a comprehensive biomarker panel and when](https://www.halftime.health/learning-center/biomarkers-who-when): Not everyone needs a comprehensive biomarker panel — but some are overdue and do not know it. Here is who benefits most and when to start testing.
- [How CGM Reveals Glucose Variability Patterns](https://www.halftime.health/learning-center/cgm-mechanism): A continuous glucose monitor tracks blood sugar every few minutes, revealing spikes, dips, and time in range that a single fasting lab draw can miss.
- [Continuous glucose monitoring for non-diabetics, explained](https://www.halftime.health/learning-center/cgm-non-diabetic): A CGM (continuous glucose monitor) tracks blood sugar around the clock. Here is what it reveals for people without diabetes and why glucose variability matters.
- [Cortisol and the HPA axis: why stress labs matter alongside peptides](https://www.halftime.health/learning-center/cortisol-hpa-axis-stress-biomarkers): Cortisol and the HPA axis explained in plain English: what stress biomarkers tell you, when to test, and why they matter alongside any peptide protocol.
- [DEXA body composition scans and peptide protocols](https://www.halftime.health/learning-center/dexa-body-composition): DEXA scans measure lean mass, fat mass, and bone density with more precision than scale weight alone. Here's how they're used as a baseline for peptide protocols.
- [How DEXA distinguishes lean mass, fat mass, and bone density](https://www.halftime.health/learning-center/dexa-mechanism): How DEXA works: two X-ray energies pass through tissue, and the attenuation ratio separates bone, fat, and lean mass into three measured compartments.
- [DEXA vs InBody vs BMI: how to actually measure body composition](https://www.halftime.health/learning-center/dexa-vs-inbody-vs-bmi-comparison): BMI is the most common body composition metric and one of the least informative. Here is how DEXA, InBody, and BMI compare — and which one to use for what.
- [DEXA body composition scans: what they measure](https://www.halftime.health/learning-center/dexa-what-it-is): DEXA scans measure lean mass, fat mass, and bone density with precision BMI can't match. Learn how the test works and what clinicians look for.
- [eGFR and cystatin C: a closer look at kidney function](https://www.halftime.health/learning-center/egfr-cystatin-c-kidney-marker): Cystatin C is a second kidney marker that cross-checks the standard eGFR calculation. Here is what it measures, why it matters, and when to ask for it.
- [Fasting glucose vs fasting insulin: two metabolic baselines](https://www.halftime.health/learning-center/fasting-glucose-vs-insulin): Fasting glucose and fasting insulin measure different things. Here is the plain-English difference, and why insulin can flag metabolic trouble years earlier.
- [Fasting insulin: the metabolic marker your standard panel might miss](https://www.halftime.health/learning-center/fasting-insulin-metabolic-marker-missed): Fasting glucose can look fine while fasting insulin is climbing for years. Here is why this lab matters — and why it is rarely on a standard panel.
- [Ferritin: the iron-storage marker that reveals more than anemia](https://www.halftime.health/learning-center/ferritin-the-iron-storage-marker-that-reveals-more-than-anemia): Ferritin measures the iron your body has stored away. Here is what high and low ferritin can signal, and why a normal hemoglobin can still hide a problem.
- [Fibrinogen: what this blood-clotting marker measures](https://www.halftime.health/learning-center/fibrinogen-blood-test-explained): Fibrinogen is a liver protein that helps blood clot and also rises with inflammation. Here's what a fibrinogen blood test measures and what the numbers mean.
- [GGT: the liver-stress enzyme that reveals hidden metabolic risk](https://www.halftime.health/learning-center/ggt-liver-stress-metabolic-marker): GGT is a liver-stress enzyme that quietly tracks metabolic risk. Here is what the reference ranges mean, what raises it, and why standard panels miss it.
- [GH and IGF-1 testing: what baseline levels tell clinicians before starting secretagogues](https://www.halftime.health/learning-center/gh-igf-1-baseline-testing-before-secretagogue-therapy): Before starting growth hormone secretagogues, a baseline IGF-1 level tells clinicians where you're starting and what range to target. Here's why it matters.
- [Haptoglobin: what this blood test measures](https://www.halftime.health/learning-center/haptoglobin-blood-test-explained): A haptoglobin blood test measures a protein that clears free hemoglobin. Here's what haptoglobin is, what low or high results can mean, and why it's ordered.
- [How HbA1c measures 90-day blood sugar patterns](https://www.halftime.health/learning-center/hba1c-mechanism): How HbA1c works in plain English: why one blood test reflects roughly three months of blood sugar, what the numbers mean, and how to read your result.
- [HbA1c vs CGM: which gives you more actionable data](https://www.halftime.health/learning-center/hba1c-vs-cgm): HbA1c shows your 3-month blood sugar average; CGM shows minute-by-minute glucose. Learn what each test measures and how to use both together.
- [HOMA-IR: the simple calculation that maps insulin resistance](https://www.halftime.health/learning-center/homa-ir-insulin-resistance-calculation): HOMA-IR in plain English: a simple formula using fasting glucose and fasting insulin that estimates insulin resistance. How to calculate it and how to read it.
- [HOMA-IR: the insulin resistance marker your standard panel might miss](https://www.halftime.health/learning-center/homa-ir-insulin-resistance-marker): HOMA-IR is a simple calculation from fasting glucose and fasting insulin that flags early insulin resistance — often before a standard panel does.
- [HOMA-IR: the insulin resistance marker your doctor might not be running](https://www.halftime.health/learning-center/homa-ir-the-insulin-resistance-marker-your-doctor-might-not-be-running): HOMA-IR is a simple math formula that turns fasting glucose and insulin into an early read on insulin resistance — usually years before standard labs flag it.
- [Homocysteine: the overlooked marker for heart and brain health](https://www.halftime.health/learning-center/homocysteine-the-overlooked-marker-for-heart-and-brain-health): Homocysteine is an amino acid in your blood, and high levels are linked to heart and brain risk. Here is what the test measures and why B vitamins matter.
- [How HRV Reflects Autonomic Nervous System Balance](https://www.halftime.health/learning-center/hrv-mechanism): HRV tracks the tiny gaps between heartbeats to reveal how your nervous system balances stress and recovery. Here is the mechanism behind the number.
- [HRV and Longevity Research: What the Published Data Shows](https://www.halftime.health/learning-center/hrv-research): Higher heart rate variability is linked to lower cardiovascular risk in published research. Here is what the HRV and longevity literature actually shows.
- [Heart rate variability: what it is and why it matters](https://www.halftime.health/learning-center/hrv-what-it-is): Heart rate variability (HRV) is the tiny time gap between heartbeats. A higher HRV usually signals a more resilient nervous system. Here's what it means.
- [hs-CRP: the inflammation marker that predicts more than most tests](https://www.halftime.health/learning-center/hs-crp-inflammation-marker-explained): hs-CRP explained in plain English: what high-sensitivity CRP measures, why it predicts cardiovascular risk, and how to read your result. Educational only.
- [IGF-1 before and after GH peptides: what the lab number is telling you](https://www.halftime.health/learning-center/igf1-before-after-gh-peptides): Clinicians track IGF-1 before and during growth hormone peptide therapy as a downstream marker. Here is what the number reflects and how to read the change in plain English.
- [IGF-1 lab reference ranges: what an optimal level looks like by age](https://www.halftime.health/learning-center/igf1-lab-reference-ranges-optimal): IGF-1 reference ranges in plain English: how a routine lab is reported, what an optimal level looks like across age, and where the conversation gets nuanced.
- [IGF-1 lab test: what the number means](https://www.halftime.health/learning-center/igf1-lab-what-it-measures): IGF-1 is the primary marker clinicians use to assess GH-axis activity. Here's what the number measures, how reference ranges are age-adjusted, and what elevations mean.
- [Who orders IGF-1 tests and what they are looking for](https://www.halftime.health/learning-center/igf1-lab-who-orders): Who orders IGF-1 tests, what the result reveals about your growth hormone axis, and when this blood test is actually worth requesting — explained plainly.
- [IGF-1 vs GH Testing: Which Lab Tells You More](https://www.halftime.health/learning-center/igf1-vs-gh-testing): IGF-1 is usually the better single screen for growth hormone activity because it stays stable in blood, while GH swings in short pulses all day.
- [Immune markers worth knowing: WBC and the NLR](https://www.halftime.health/learning-center/immune-markers-wbc-nlr): WBC and NLR are two immune markers on a standard blood test. Here's what they measure, what the ranges mean, and when a number warrants a call.
- [The inflammation panel: hs-CRP, IL-6, and homocysteine together](https://www.halftime.health/learning-center/inflammation-panel-crp-il6-homocysteine): hs-CRP, IL-6, and homocysteine each flag a different kind of inflammation. Here is why clinicians read all three together, not one at a time.
- [Insulin resistance in perimenopause: the metabolic shift that changes everything](https://www.halftime.health/learning-center/insulin-resistance-in-perimenopause-the-metabolic-shift-that-changes-everything): Perimenopause changes how your body handles insulin — often before other symptoms appear. Here's what that shift looks like on a lab panel and why it matters.
- [Lab quality and CLIA certification: what it means for your results](https://www.halftime.health/learning-center/lab-quality-clia): CLIA certification is the federal quality standard for U.S. labs. Learn what it checks, who oversees it, and why it matters for your bloodwork.
- [LDH blood test explained in plain English](https://www.halftime.health/learning-center/ldh-blood-test-explained): An LDH blood test measures an enzyme released when tissues are damaged. Here is what LDH is, what the test shows, and what a normal level looks like.
- [Lipoprotein(a): the inherited heart-risk marker most people never test](https://www.halftime.health/learning-center/lipoprotein-a-the-inherited-heart-risk-marker-most-people-never-test): Lipoprotein(a), or Lp(a), is an inherited cholesterol particle linked to heart risk. Here is what the Lp(a) blood test measures and why it is rarely run.
- [The longevity biomarker panel: markers clinicians track](https://www.halftime.health/learning-center/longevity-biomarker-panel): A longevity biomarker panel tracks markers like ApoB, hs-CRP, HbA1c, and IGF-1. Here's what the panel measures and what the aging research links to it.
- [Low testosterone: when the number and the symptoms both matter](https://www.halftime.health/learning-center/low-testosterone-diagnosis): Low testosterone diagnosis in plain English — why one number is not enough, what the AUA threshold is, and the symptom picture that turns a lab result into a clinical decision.
- [The men's midlife biomarker panel: what to include in 2026](https://www.halftime.health/learning-center/mens-midlife-panel-2026): The men's midlife biomarker panel in plain English — what to include, why each marker matters, and how the 2026 list updates the standard physical.
- [The modern metabolic panel: beyond glucose to insulin and ApoB](https://www.halftime.health/learning-center/metabolic-panel-2026-insulin-apob): A standard metabolic panel misses early trouble. Here is why fasting insulin and ApoB belong on a modern metabolic health panel, and what each number tells you.
- [Who should track metabolic biomarkers and how often](https://www.halftime.health/learning-center/metabolic-panel-who-when): Track metabolic biomarkers if you have risk factors like family history, ancestry, or GLP-1 therapy — retest every 3 to 6 months, then annually once stable.
- [The omega-3 index test: what your baseline tells you](https://www.halftime.health/learning-center/omega-3-index-testing-what-the-research-shows-about-baseline-measurement): The omega-3 index measures how much EPA and DHA sit in your red blood cells. Here is what the number means and why a baseline matters, in plain English.
- [Peptide protocol monitoring: which biomarkers to track](https://www.halftime.health/learning-center/peptide-protocol-monitoring-which-biomarkers-to-track-and-why): Good peptide protocols are monitored, not set and forgotten. Here are the biomarkers clinicians commonly track and why each one matters, in plain English.
- [RDW: the red blood cell marker linked to healthy aging](https://www.halftime.health/learning-center/rdw-red-cell-distribution-width): Red cell distribution width (RDW) measures how varied your red blood cells are in size. Here is what a high RDW can signal about your overall health.
- [Reference range vs optimal range: what lab results mean](https://www.halftime.health/learning-center/reference-vs-optimal-range-trap): A lab reference range covers the middle 95% of a healthy population — not your personal ideal. Here's what the gap between 'in range' and 'optimal' means.
- [Reticulocyte count: what this blood test measures](https://www.halftime.health/learning-center/reticulocyte-count-explained): A reticulocyte count measures young red blood cells in your blood. Here's what the test shows, why it's ordered, and what high or low results can mean.
- [Standard vs Advanced Lipid Panel: What the Extra Tests Add](https://www.halftime.health/learning-center/standard-vs-advanced-lipid): Standard vs advanced lipid panel: what ApoB and Lp(a) testing add beyond total cholesterol, LDL, HDL, and triglycerides, and who actually needs it.
- [Testosterone lab tests: total vs free vs bioavailable](https://www.halftime.health/learning-center/testosterone-lab-types): Total, free, and bioavailable testosterone explained. Which test measures what, why clinicians order all three, and how to read it. Educational only.
- [Who orders testosterone panels and what they are evaluating](https://www.halftime.health/learning-center/testosterone-lab-who-orders): Who orders a testosterone blood test, what total and free testosterone measure, and what clinicians are actually looking for in the results.
- [Testosterone panels for men: what total, free, and SHBG mean together](https://www.halftime.health/learning-center/testosterone-panels-total-free-shbg): A testosterone panel is three numbers, not one. Plain-English breakdown of total testosterone, free testosterone, and SHBG — and why all three matter together.
- [Testosterone testing in men under 50: total, free, and bioavailable](https://www.halftime.health/learning-center/testosterone-testing-in-men-under-50-what-total-free-and-bioavailable-numbers-me): Total, free, and bioavailable testosterone measure different things. Here's what each number means for men under 50, and why one low reading isn't a diagnosis.
- [Thyroid testing explained: TSH, free T4, and free T3](https://www.halftime.health/learning-center/thyroid-testing-explained-tsh-free-t4-and-free-t3): TSH, free T4, and free T3 are the core thyroid labs. Here is what each one measures, how they fit together, and why one number rarely tells the whole story.
- [Tracking progress on a peptide protocol: which numbers actually matter](https://www.halftime.health/learning-center/tracking-progress-peptide-protocol): A plain-English guide to which numbers actually matter on a peptide protocol — what to track, how often, and what counts as a meaningful change.
- [Uric acid: the metabolic marker beyond gout](https://www.halftime.health/learning-center/uric-acid-metabolic-marker): Uric acid is best known for gout, but research links it to metabolic and heart health too. Here's what the marker is and what high levels may signal.
- [What are biomarkers, and why do they matter for peptide protocols?](https://www.halftime.health/learning-center/what-are-biomarkers-peptide-protocols): A biomarker is anything measurable that tells you how a system is functioning. Here is what they mean for peptide protocols, and the labs most clinicians check before starting.
- [The women's midlife biomarker panel: what to include in 2026](https://www.halftime.health/learning-center/womens-midlife-panel-2026): The women's midlife biomarker panel — what to test in your 40s and 50s. Hormones, metabolic, inflammation, bone, thyroid. Plain-English guide for patients.

## Women's Health
- [Allantoin: the gentle soother in your skincare](https://www.halftime.health/learning-center/allantoin-skincare-explained): Allantoin is a gentle skincare ingredient that soothes, hydrates, and smooths rough skin. Here's what it does, how it works, and who it suits best.
- [Alpha arbutin in skincare explained simply](https://www.halftime.health/learning-center/alpha-arbutin-skincare-explained): Alpha arbutin is a gentle skin brightener that slows the enzyme behind dark spots. Here is what it is, how it works, and what the research shows.
- [Azelaic acid: what this skincare ingredient actually does](https://www.halftime.health/learning-center/azelaic-acid-skincare-explained): Azelaic acid is a gentle skincare acid studied for redness, breakouts, and uneven tone. Here is how it works and what the dermatology research shows.
- [Bakuchiol: a gentler retinol alternative, explained](https://www.halftime.health/learning-center/bakuchiol-skincare-explained): Bakuchiol is a plant-derived ingredient studied as a gentler alternative to retinol. Here's what it is, how it works, and how it compares to retinol.
- [Beta-glucan in skincare: what it does for skin](https://www.halftime.health/learning-center/beta-glucan-skincare-explained): Beta-glucan in skincare is a soothing sugar from oats and yeast studied for hydration and barrier support. Here's what beta-glucan does for skin and the limits.
- [Centella asiatica (cica): what it does for skin](https://www.halftime.health/learning-center/centella-asiatica-cica-skincare): Centella asiatica, often called cica, is a soothing plant extract used in skincare. Here's what it does, how it works, and who it suits best.
- [CJC-1295 and ipamorelin for women: sleep, skin, and recovery](https://www.halftime.health/learning-center/cjc-ipamorelin-women-sleep-skin-recovery): CJC-1295 plus ipamorelin in midlife women, in plain English: how it is studied for sleep, skin, and recovery, and what the literature does and does not show.
- [Collagen peptides vs GHK-Cu: two different levels of action](https://www.halftime.health/learning-center/collagen-peptides-vs-ghk-cu-levels): Collagen peptides feed the building blocks. GHK-Cu sends a signal to rebuild. Same word, two different jobs in the skin — a plain-English comparison.
- [Collagen and the skin: what the peptide literature actually shows](https://www.halftime.health/learning-center/collagen-skin-primer): Collagen is the protein that gives skin its shape. Here is what published research actually says about peptides and collagen — and what is still being studied.
- [Collagen synthesis: what the peptide literature actually shows](https://www.halftime.health/learning-center/collagen-synthesis-literature): What peer-reviewed research says about peptides and collagen synthesis — type I and III collagen, ECM remodeling, MMP regulation, and where the data has limits.
- [How collagen synthesis works and where it declines with age](https://www.halftime.health/learning-center/collagen-synthesis-mechanism): How the body builds collagen — fibroblasts, hydroxylation, and the cross-linking step that gives skin and tissue tensile strength — and where the process slows after 30.
- [The original GHK-Cu research: what Pickart actually found](https://www.halftime.health/learning-center/copper-peptide-pickart-research-review): The original GHK-Cu research from Dr. Loren Pickart in plain English: a tiny peptide isolated from blood plasma in the 1970s with decades of skin and tissue repair studies.
- [Copper peptides 101: what they are and what they do](https://www.halftime.health/learning-center/copper-peptides-101): Copper peptides are small proteins bound to copper — sold as topical cosmetics or, in another form, compounded by prescription. Here's the difference.
- [Dermastamp and microneedle basics](https://www.halftime.health/learning-center/dermastamp-microneedle-basics): What microneedling does to skin at a biological level, the difference between clinical and at-home devices, and what the dermatology literature says about peptide delivery.
- [Collagen drinks vs signaling peptides: what's the difference?](https://www.halftime.health/learning-center/drinkable-collagen-vs-signaling-peptides): Collagen drinks and signaling peptides both target skin — but they work in completely different ways. Here's what the research actually says about each.
- [Estrogen decline and skin aging: where peptides fit in](https://www.halftime.health/learning-center/estrogen-decline-skin-aging-peptides): Estrogen decline thins skin, slows collagen, and shifts how skin holds water. A plain-English look at the biology — and where copper peptides like GHK-Cu fit in.
- [GHK-Cu FAQ: the top questions answered](https://www.halftime.health/learning-center/ghk-cu-faqs): GHK-Cu FAQ — what it is, how it works, who it is for, side effects, and regulatory status. Plain-English answers to the most common copper peptide questions.
- [GHK-Cu for hair: what the collagen-stimulating research shows](https://www.halftime.health/learning-center/ghk-cu-hair-regrowth-research): GHK-Cu and hair: copper peptides have decades of research on follicle biology and collagen. Here is what the studies actually show — and what they don't.
- [GHK-Cu injectable vs topical: two routes, two different mechanisms](https://www.halftime.health/learning-center/ghk-cu-injectable-vs-topical-mechanism): GHK-Cu injectable vs topical: how delivery changes the mechanism, what reaches your skin, and what the research shows. Compounded injectable GHK-Cu is not FDA-approved.
- [How GHK-Cu promotes collagen synthesis: the mechanism](https://www.halftime.health/learning-center/ghk-cu-mechanism): GHK-Cu is a small copper-binding peptide that signals skin repair. Here is the mechanism in plain English: what it does to fibroblasts, collagen, and the dermal matrix.
- [GHK-Cu research: what the published dermatology literature shows](https://www.halftime.health/learning-center/ghk-cu-research): GHK-Cu has decades of dermatology research behind it, mostly in cell and small-scale skin studies. Here is what the GHK-Cu research base actually shows, in plain English.
- [GHK-Cu side effects and what to know before using it](https://www.halftime.health/learning-center/ghk-cu-side-effects): GHK-Cu side effects in dermatology trials are usually mild: brief redness, mild itch, occasional metallic taste with injectable forms. Here is what to flag.
- [GHK-Cu: the copper peptide and skin biology](https://www.halftime.health/learning-center/ghk-cu-skin-peptide): What GHK-Cu is, how it interacts with dermal biology, and what the published research actually says about this copper-binding tripeptide.
- [GHK-Cu topical vs injection: different delivery, different data](https://www.halftime.health/learning-center/ghk-cu-topical-vs-inject): Topical GHK-Cu serums and injectable GHK-Cu follow very different pharmacokinetics. Here's what the dermal penetration literature actually shows.
- [Why GHK-Cu searches surged in 2026](https://www.halftime.health/learning-center/ghk-cu-trending-2026-why): GHK-Cu searches surged in 2026 in plain English: regulatory news, social posts, and a real research base around skin and hair drove the renewed attention.
- [GHK-Cu vs hyaluronic acid: two different jobs in the skin](https://www.halftime.health/learning-center/ghk-cu-vs-hyaluronic-acid): GHK-Cu and hyaluronic acid are often pitched as rivals, but they do completely different jobs. Here is a clear comparison of mechanism, evidence, and use.
- [GHK-Cu vs retinol: how copper peptides and vitamin A compare](https://www.halftime.health/learning-center/ghk-cu-vs-retinol): GHK-Cu and retinol both have skin research behind them, but they work through different pathways. Here is the plain-English GHK-Cu vs retinol comparison, with what the evidence supports.
- [GHK-Cu: what the copper peptide actually is](https://www.halftime.health/learning-center/ghk-cu-what-it-is): GHK-Cu explained in plain English. What this copper peptide is, why it shows up in skin research, and what the literature shows. Educational only.
- [Who asks about GHK-Cu, and the skin questions behind the search](https://www.halftime.health/learning-center/ghk-cu-who-asks): Who asks about GHK-Cu and why: the real skin and hair questions behind the copper peptide search, plus what the published research can and cannot answer yet.
- [GHK-Cu and wound healing: what the clinical data actually says](https://www.halftime.health/learning-center/ghk-cu-wound-healing-clinical-summary): GHK-Cu is studied for skin repair and wound healing. Here is a plain-English summary of the human and animal data — and what it does not yet show.
- [GHK-Cu and wound healing: the regenerative mechanism explained](https://www.halftime.health/learning-center/ghk-cu-wound-healing-mechanism): GHK-Cu wound healing in plain English: how a tiny copper-binding peptide signals tissue repair, what the research describes, and where the evidence stops.
- [Peptides and hair regrowth: what the published literature reports](https://www.halftime.health/learning-center/hair-regrowth-peptides-literature): Peptides studied for hair regrowth — GHK-Cu, thymosin beta-4 fragments, biomimetics. Plain-English research summary. Compounded peptides are not FDA-approved.
- [Hyaluronic acid: how the humectant actually works](https://www.halftime.health/learning-center/hyaluronic-acid-humectant-explained): Hyaluronic acid is a humectant that holds water in skin like a sponge. Here is how it works, what it can and cannot do, and how to use it well.
- [Kojic acid in skincare explained simply](https://www.halftime.health/learning-center/kojic-acid-skincare-explained): Kojic acid is a skin-brightening ingredient that blocks the enzyme behind dark spots. Here is what it is, how it works, and what research shows.
- [Mandelic acid: the gentle alpha hydroxy acid](https://www.halftime.health/learning-center/mandelic-acid-skincare-explained): Mandelic acid is a large, slow-penetrating alpha hydroxy acid known for being gentle on sensitive skin. Here's what mandelic acid is and what research shows.
- [Matrixyl and argireline: the cosmetic peptide labels decoded](https://www.halftime.health/learning-center/matrixyl-argireline-cosmetic-peptides): Matrixyl and argireline are trademarked cosmetic peptide ingredients in serums. Here's what they are, what they're marketed to do, and the limits.
- [Microneedling and topical peptides: the dermastamp protocol](https://www.halftime.health/learning-center/microneedling-peptides-protocol): Microneedling with topical peptides explained in plain English: how the dermastamp works, what the research supports, and the safety basics worth knowing first.
- [Microneedling with peptides: how delivery actually works](https://www.halftime.health/learning-center/microneedling-with-peptides-delivery): Microneedling pairs micro-channels in skin with topical peptides like GHK-Cu. Here is how the delivery actually works and what the published evidence supports.
- [Niacinamide vs peptides: what each does for skin](https://www.halftime.health/learning-center/niacinamide-vs-peptides-skincare): Niacinamide and peptides are popular skincare ingredients that work in different ways. Here's what each does, how they compare, and whether to combine them.
- [Panthenol (provitamin B5): what it does for skin](https://www.halftime.health/learning-center/panthenol-skincare-explained): Panthenol, or provitamin B5, is a humectant that pulls water into skin and supports the barrier. Here's what it does, how it works, and who it suits.
- [What 'peptide' on a skincare label actually means](https://www.halftime.health/learning-center/peptide-on-skincare-label-meaning): Peptides in skincare are cosmetic ingredients — not drugs. Here's what the INCI names mean, how the main types differ, and what the research actually supports.
- [Peptide stack for menopause: addressing the five most common symptoms](https://www.halftime.health/learning-center/peptide-stack-menopause-five-symptoms): Menopause shifts five things at once: sleep, skin, mood, body composition, and libido. A plain-English guide to which peptides have research behind them — and which do not.
- [Peptides for acne and skin inflammation: what the research shows](https://www.halftime.health/learning-center/peptides-acne-skin-inflammation): Peptides like GHK-Cu have anti-inflammatory effects in dermatology research. Here's what the literature actually shows for acne and inflamed skin.
- [Peptides and collagen: beyond the topical creams](https://www.halftime.health/learning-center/peptides-collagen-beyond-topical): Why injectable peptides like GHK-Cu signal collagen differently than topical creams or oral collagen powders. What the dermatology literature actually shows.
- [Peptides and postpartum recovery: a careful conversation](https://www.halftime.health/learning-center/peptides-postpartum-recovery-conversation): Peptides and postpartum recovery — a careful conversation about what is studied, what is unknown during breastfeeding, and what a clinician needs to weigh.
- [Peptides and hair thinning in perimenopause: what the research supports](https://www.halftime.health/learning-center/peptides-women-hair-thinning-perimenopause): Hair thinning in perimenopause has multiple causes. GHK-Cu has small published hair-related studies. The workup of underlying causes comes first.
- [Peptide therapy for women in perimenopause: what changes in your 40s](https://www.halftime.health/learning-center/peptides-women-perimenopause-what-changes): Perimenopause shifts hormones, sleep, and skin in ways that peptide therapy is being studied to address. Here is a plain-English starter framework — and what to ask a clinician.
- [Perimenopause explained: what is happening and when](https://www.halftime.health/learning-center/perimenopause-explained): Perimenopause is the years-long transition before menopause when ovarian hormones swing and shift. Here is what is happening — and why the timing varies so much.
- [Perimenopause FAQ: the questions women in their 40s ask](https://www.halftime.health/learning-center/perimenopause-faqs): A direct-answer FAQ for women in their 40s navigating perimenopause — what is normal, what is not, when to test hormones, and where peptides fit in.
- [How estrogen, progesterone, and testosterone shift in perimenopause](https://www.halftime.health/learning-center/perimenopause-hormone-shifts): Perimenopause is not a steady decline. Estrogen swings, progesterone falls earlier, testosterone drifts down. Here is what shifts when, with the literature.
- [Perimenopause symptoms: which are common and which need attention](https://www.halftime.health/learning-center/perimenopause-symptoms): Perimenopause symptoms in plain English — what is normal, what is common, and which symptoms deserve a clinician call. The full midlife symptom map.
- [Perimenopause vs menopause: how the two stages differ](https://www.halftime.health/learning-center/perimenopause-vs-menopause): Perimenopause vs menopause in plain English — what changes, when it starts, why the experience differs, and what each stage actually means medically.
- [Who is in perimenopause and who does not know it yet](https://www.halftime.health/learning-center/perimenopause-who-affected): Perimenopause can start in the late 30s and last over a decade. Most women aren't told. Here's a plain-English read on who is in it — and who doesn't know.
- [Sermorelin for women: growth hormone decline and what it looks like](https://www.halftime.health/learning-center/sermorelin-women-gh-decline): Sermorelin for women in plain English: how growth hormone changes through midlife, what a GHRH analog does, and what the published literature actually supports.
- [The skin barrier and ceramides, explained](https://www.halftime.health/learning-center/skin-barrier-ceramides-explained): The skin barrier is your outer shield, and ceramides are its mortar. Here's what the barrier does, the role of ceramides, and how to support it.
- [Skin biomarkers: how to actually measure peptide results](https://www.halftime.health/learning-center/skin-biomarker-measuring-peptide-results): Skin peptide results are easier to feel than to prove. Here are the biomarkers — elasticity, hydration, thickness, melanin — that researchers actually measure.
- [Skin peptides 101: a primer for women who want the science](https://www.halftime.health/learning-center/skin-peptides-101-women): Skin peptides 101 in plain English: GHK-Cu and a few research-backed signaling peptides that may support collagen and skin barrier. The honest version, not the marketing one.
- [Who asks about peptides for skin, and what drives it](https://www.halftime.health/learning-center/skin-peptides-who-asks): Skin peptides draw questions from people frustrated with creams that promise more than they deliver. Here is who searches and what they want.
- [Squalane: the lightweight moisturizer your skin recognizes](https://www.halftime.health/learning-center/squalane-skincare-explained): Squalane is a lightweight oil that mirrors a moisturizer your skin already makes. Here is how it softens skin and locks in water, per the research.
- [Tranexamic acid: the ingredient studied for melasma](https://www.halftime.health/learning-center/tranexamic-acid-skincare-explained): Tranexamic acid is studied for melasma and dark patches by calming a UV-driven pigment pathway. Here's what tranexamic acid is and what the research shows.
- [Urea in skincare: the moisturizer that also exfoliates](https://www.halftime.health/learning-center/urea-in-skincare-explained): Urea in skincare is a humectant at low doses and an exfoliant at higher ones. Here's what urea does for skin, how concentration changes its job, and cautions.
- [Vitamin C for skin: what the research actually shows](https://www.halftime.health/learning-center/vitamin-c-skincare-explained): Vitamin C for skin supports collagen and helps guard against sun damage. Here is how topical vitamin C works and what the research really shows.

## Regulatory
- [The 12 peptides removed from FDA restriction in 2026: what each one does](https://www.halftime.health/learning-center/12-peptides-removed-fda-restriction-2026): The peptides reclassified by the FDA in 2026 in plain English: a short reference of the compounds named in the reclassification announcement and what each one does.
- [503A pharmacy regulations: the DQSA framework explained](https://www.halftime.health/learning-center/503a-dqsa-framework): The DQSA defines what 503A pharmacies can and cannot compound. Here is the framework in plain English, why it exists, and what it means for peptide patients.
- [BPC-157 and the FDA: Category 2 status and what comes next](https://www.halftime.health/learning-center/bpc-157-category-2): BPC-157 was placed in FDA Category 2 in 2023. A February 2026 HHS announcement proposed returning it to Category 1. Here is where the formal process actually stands.
- [BPC-157 in 2026: what changed, what hasn't, and what to expect](https://www.halftime.health/learning-center/bpc-157-legal-again-2026): BPC-157 status in 2026: the February HHS announcement signaled intent to revisit Category 2 peptides, but the formal FDA notice is still pending. Here is the current state.
- [Category 1 vs Category 2 peptides: the access framework](https://www.halftime.health/learning-center/category-1-vs-category-2): The FDA's Category 1 and Category 2 framework determines which peptides compounding pharmacies can legally prepare. Here's how it works.
- [Category 2 peptides: what the access limits mean for patients](https://www.halftime.health/learning-center/category-2-patient-risk): FDA Category 2 means peptides like BPC-157 and TB-500 are not currently available from 503A compounding pharmacies. Here is what that means for patients.
- [Who is affected by the Category 1 vs 2 peptide framework](https://www.halftime.health/learning-center/category-framework-who-affected): The FDA's Category 1 vs Category 2 peptide framework shapes what compounding pharmacies can prepare. Here is who it affects and what it means.
- [Who actually makes compounded peptides? The supply chain](https://www.halftime.health/learning-center/cdmo-peptide-supply-chain): Compounded peptides pass through API makers, CDMOs, and licensed pharmacies before reaching patients. Here is how the supply chain actually works.
- [CJC-1295 regulatory and compounding status in 2026](https://www.halftime.health/learning-center/cjc-1295-regulatory): CJC-1295 is not FDA-approved and sits in the FDA's Category 2 for 503A compounding. Here's what its regulatory status means for access in 2026.
- [AI-designed peptides: how computers invent new molecules](https://www.halftime.health/learning-center/de-novo-peptide-design-rfdiffusion): AI tools like RFdiffusion can now design peptides that have never existed. Here's how computational protein design works and what it means for medicine.
- [FDA's March 2026 wave: 30 telehealth warning letters explained](https://www.halftime.health/learning-center/fda-30-telehealth-warning-letters-2026): FDA sent ~30 warning letters to telehealth companies in March 2026 over compounded GLP-1 marketing and prescribing. What was flagged, and what it means for patient access.
- [The FDA 503A bulks list: how a peptide qualifies to be compounded](https://www.halftime.health/learning-center/fda-503a-bulks-list-explained): The FDA 503A bulks list controls which bulk substances pharmacies may compound. Here's how a peptide gets on it — and why some can't be compounded now.
- [FDA accelerated approval pathway, explained](https://www.halftime.health/learning-center/fda-accelerated-approval-pathway): FDA accelerated approval lets serious-disease drugs reach patients sooner using a surrogate endpoint, with confirmatory trials required after. Here's how.
- [FDA boxed warning: the strongest label warning](https://www.halftime.health/learning-center/fda-boxed-warning-explained): An FDA boxed warning is the agency's strongest drug label warning. Here's what a boxed warning is, when the FDA requires one, and what it means for patients.
- [FAERS: how the FDA tracks drug side effects after approval](https://www.halftime.health/learning-center/fda-faers-adverse-event-reporting): FAERS is the FDA database that collects drug side-effect reports after approval. Here is how it works and what its public dashboard can and cannot tell you.
- [FDA import alerts: why ordering peptides from overseas is risky](https://www.halftime.health/learning-center/fda-import-alerts-why-ordering-peptides-from-overseas-is-risky): FDA import alerts let inspectors detain products at the border. Here is what they mean for peptides ordered overseas and why the personal-use myth misleads.
- [FDA orphan drug designation: rare-disease incentives](https://www.halftime.health/learning-center/fda-orphan-drug-designation-explained): FDA orphan drug designation gives rare-disease drug makers incentives like tax credits and 7 years of exclusivity. Here's what it is, and what it is not.
- [What FDA's PCAC briefing documents actually propose](https://www.halftime.health/learning-center/fda-pcac-briefing-docs-july-2026): Ahead of the July 23-24, 2026 meeting, FDA's briefing documents propose that seven peptides not be added to the 503A Bulks List. Here is what that means.
- [How the FDA categorizes peptides for 503A compounding](https://www.halftime.health/learning-center/fda-peptide-categorization-mechanism): The FDA sorts compounding-eligible peptides into Category 1 and Category 2. Here's how the sorting works, why it matters, and what changed in 2023.
- [What the April 2026 FDA peptide reclassification path actually means](https://www.halftime.health/learning-center/fda-reclassification-april-2026-explained): The April 2026 reclassification path is in motion but not finished. Here is what is actually on the docket, what changed, and what compounding pharmacies can do today.
- [FDA REMS: drug safety programs explained](https://www.halftime.health/learning-center/fda-rems-programs): FDA REMS are drug safety programs for medications with serious risks. Here's what a REMS is, why the FDA requires one, and what it can include.
- [The FDA Sentinel Initiative: drug safety after approval](https://www.halftime.health/learning-center/fda-sentinel-initiative): The FDA Sentinel Initiative actively monitors drug and vaccine safety after approval using health claims data — not voluntary reports. Here is how it works.
- [How a peptide becomes a prescription medication](https://www.halftime.health/learning-center/how-a-peptide-goes-from-research-compound-to-prescription-medication): How does a peptide go from a lab compound to a prescription medicine? Here is the path through research, trials, and approval, explained in plain English.
- [IGF-1 LR3 Regulatory Status: Where It Actually Stands in 2026](https://www.halftime.health/learning-center/igf-1-lr3-regulatory): IGF-1 LR3 regulatory status in 2026: why it sits outside the standard 503A compounding framework, and what that means for legitimate access today.
- [Ipamorelin Regulatory Status: Compounding Access in 2026](https://www.halftime.health/learning-center/ipamorelin-regulatory): Ipamorelin regulatory status in 2026: the FDA classifies it as Category 2, so 503A pharmacies cannot compound it now, pending a proposed return to Category 1.
- [Kisspeptin-10 Regulatory Status: Where It Actually Stands in 2026](https://www.halftime.health/learning-center/kisspeptin-10-regulatory): Kisspeptin-10 regulatory status in 2026: why it sits outside the 503A compounding framework as a research tool, and what that means for legitimate access.
- [KPV Category 2 status: current compounding access explained](https://www.halftime.health/learning-center/kpv-regulatory): KPV's regulatory status: removed from FDA Category 2 in April 2026, but compounding still needs a separate Pharmacy Compounding Advisory Committee review.
- [LegitScript and accreditation marks: what they actually certify](https://www.halftime.health/learning-center/legitscript-accreditation-marks): What is LegitScript certification? A plain-English guide to what pharmacy accreditation marks like LegitScript and .pharmacy verify — and what they don't.
- [MK-677 Regulatory Status: Compounding Access in 2026](https://www.halftime.health/learning-center/mk-677-regulatory): MK-677 is not FDA-approved as a drug. Here is its regulatory status after the April 2026 HHS Category 2 order and what access looks like now.
- [MOTS-c Regulatory Status: Category 2 Access in 2026](https://www.halftime.health/learning-center/mots-c-regulatory): MOTS-c remains an FDA Category 2 peptide in 2026, so 503A pharmacies cannot compound it yet. Here is its current status and what could change it.
- [NAD+ Regulatory Status: Compounding and Access in 2026](https://www.halftime.health/learning-center/nad-plus-regulatory): Injectable NAD+ is not FDA-approved. It is compounded by 503A pharmacies, and the FDA is still evaluating NAD for its bulk drug substances list.
- [Oxytocin: prescription status and compounded access](https://www.halftime.health/learning-center/oxytocin-regulatory): Injectable oxytocin is FDA-approved for labor, but compounded intranasal oxytocin is not. Here is how oxytocin's regulatory status and access actually work.
- [The PCAC advisory committee: what it is and why it matters](https://www.halftime.health/learning-center/pcac-advisory-committee-explained): PCAC is the advisory committee that recommends which compounds 503A pharmacies can prepare. Plain-English explainer of how it works and why peptides are on its agenda.
- [What the July 2026 PCAC meeting could change](https://www.halftime.health/learning-center/pcac-july-2026-meeting): The FDA's Pharmacy Compounding Advisory Committee meets in July 2026 to review peptide reclassification. Here's what PCAC does, how it works, and what's on the agenda.
- [PCAC July 2026 meeting: what the advisory committee is reviewing](https://www.halftime.health/learning-center/pcac-july-2026-preview): The FDA's Pharmacy Compounding Advisory Committee meets in July 2026. Here is what the committee reviews, why it matters for peptide access, and what to watch.
- [Peptide misinformation: the most repeated false claims of 2026](https://www.halftime.health/learning-center/peptide-misinformation-2026-false-claims): The most repeated false claims about peptides circulating in 2026 — and what the FDA and Federal Register actually say. Calm, sourced, factual.
- [How peptides came to be regulated: DQSA, FDCA, and compounding](https://www.halftime.health/learning-center/peptide-regulation-history): Peptide regulation traces to the FDCA, 1997 FDAMA, and 2013 DQSA, passed after a deadly 2012 meningitis outbreak at one U.S. compounding pharmacy.
- [The 2026 peptide regulatory landscape: a plain-English map](https://www.halftime.health/learning-center/peptide-regulatory-landscape-2026): The 2026 peptide regulatory landscape in plain English — Category 1 vs 2, the HHS announcement, the PCAC meeting, and what access looks like today.
- [Why some peptides are still Category 2 after the 2026 reclassification news](https://www.halftime.health/learning-center/peptides-still-category-2-why): The February 2026 HHS announcement signaled change. Several peptides remain Category 2. Here is why — and what has and has not actually moved.
- [Why a prescription is a safety feature, not a hurdle](https://www.halftime.health/learning-center/prescription-is-a-safety-feature): A prescription is a safety check, not red tape. Here is what it verifies, why gray-market peptides skip it, and what the data say about online pharmacies.
- [The ProPublica peptide safety story: what it got right and wrong](https://www.halftime.health/learning-center/propublica-peptide-safety-response): ProPublica raised real safety questions about compounded peptides. Here's what the reporting got right, where context was thin, and what patients should actually know.
- [PT-141 regulatory status: FDA approval and compounding access](https://www.halftime.health/learning-center/pt-141-regulatory): PT-141 regulatory status: Vyleesi is FDA-approved for HSDD; compounded bremelanotide is prepared by 503A pharmacies. Access landscape in 2026.
- [PT-141 regulatory status in 2026: what is actually approved](https://www.halftime.health/learning-center/pt-141-regulatory-status-2026): PT-141 (bremelanotide) is FDA-approved as Vyleesi for one specific indication. Compounded PT-141 is a different access path. Here is the 2026 regulatory picture in plain English.
- [How to Read an FDA Action Without the Headline Spin](https://www.halftime.health/learning-center/reading-fda-action-without-spin): Does an FDA warning letter or guidance document actually ban a product? A plain-English guide to what FDA actions legally mean, before the headline spins it.
- [Who is affected by peptide regulatory changes and how](https://www.halftime.health/learning-center/regulatory-changes-who-affected): Peptide regulatory changes ripple out to patients, prescribers, and pharmacies in different ways. Here is who is affected, how, and what each group can do next.
- [The RFK February 2026 peptide announcement: what it means](https://www.halftime.health/learning-center/rfk-announcement-analysis): In February 2026, HHS signaled a path for several peptides off the FDA Category 2 list. Here is what the announcement said and what is still pending.
- [RFK Jr. and the Category 2 reversal: a clear timeline of what's actually happened](https://www.halftime.health/learning-center/rfk-peptide-category2-reversal-timeline): A plain-English timeline of how peptides moved from FDA Category 2 in 2023 toward a proposed Category 1 reversal in 2026. Compounded peptides are not FDA-approved.
- [The February 2026 HHS announcement on peptide reclassification](https://www.halftime.health/learning-center/rfk-peptide-reclassification): In February 2026, HHS proposed returning seven Category 2 peptides to Category 1 status. Here's what 'proposed' actually means procedurally — and what hasn't changed yet.
- [Selank regulatory status and Category 2 access in 2026](https://www.halftime.health/learning-center/selank-regulatory): Selank is an FDA Category 2 peptide, not available from 503A pharmacies in 2026. Here is what that means and what a February 2026 HHS proposal could change.
- [Semax regulatory status: Category 2 and the reclassification path](https://www.halftime.health/learning-center/semax-regulatory): Semax's regulatory status: removed from FDA Category 2 in April 2026, but compounding still needs a separate Pharmacy Compounding Advisory Committee review.
- [Sermorelin regulatory status and compounding access in 2026](https://www.halftime.health/learning-center/sermorelin-regulatory-status): Sermorelin in 2026: from the FDA-approved Geref era to today's 503A compounding access, with the regulatory history and current rules in plain English.
- [TB-500 regulatory status: Category 2 and the path forward](https://www.halftime.health/learning-center/tb-500-category-2): TB-500 is currently classified as a Category 2 peptide by the FDA. A February 2026 HHS announcement proposed returning it to Category 1. Here is where the formal process actually stands.
- [10 questions to ask before buying any peptide online](https://www.halftime.health/learning-center/ten-questions-before-buying-peptides): Before buying any peptide online, ask these questions. Here is a plain-English safety checklist and what regulators say about rogue online pharmacies.
- [Tesamorelin Regulatory Status: FDA Approval and Compounding Context](https://www.halftime.health/learning-center/tesamorelin-regulatory): Tesamorelin (Egrifta) is FDA-approved for HIV lipodystrophy, but a compounded version is not FDA-approved. Here's what that distinction means.
- [The 'banned overnight' myth: what actually happened to peptides in 2023](https://www.halftime.health/learning-center/the-banned-overnight-myth-what-actually-happened-to-peptides-in-2023): The 2023 peptide story is told as a sudden ban. The actual story is slower and more procedural. Here is what really happened, in order, and why it matters.
- [FDA-approved peptide drugs vs gray-market peptides](https://www.halftime.health/learning-center/the-difference-between-fda-approved-peptide-drugs-and-gray-market-peptides): FDA-approved peptide drugs, compounded peptides, and gray-market peptides are three different things. Here is how to tell them apart, in plain English.
- [The PCAC: who decides which peptides are accessible](https://www.halftime.health/learning-center/the-pcac-advisory-committee-who-decides-which-peptides-are-accessible): The FDA's Pharmacy Compounding Advisory Committee (PCAC) decides which peptides pharmacies can compound. Here's how the process works and why it matters.
- [The Ryan Haight Act and online prescribing: what it means for telehealth access](https://www.halftime.health/learning-center/the-ryan-haight-act-and-online-prescribing-what-it-means-for-telehealth-access): The Ryan Haight Act sets the rules for prescribing controlled medications online. Here is what it is and why it shapes telehealth access in plain English.
- [WADA prohibited peptides 2026: what's on the list and why](https://www.halftime.health/learning-center/wada-prohibited-peptides-2026): WADA's 2026 prohibited list, explained. Which peptides are banned in tested sport, and what the Enhanced Games changes. Educational only.
- [What RFK Jr's Rogan interview actually said about peptide access vs. what the headlines claimed](https://www.halftime.health/learning-center/what-rfk-jrs-rogan-interview-actually-said-about-peptide-access-vs-what-headline): RFK Jr's Rogan appearance sparked headlines about peptides. Here's what he actually said, what it means for access, and what hasn't changed.
- [Why the 2023 peptide compounding ban happened: the FDA's rationale](https://www.halftime.health/learning-center/why-the-2023-peptide-compounding-ban-happened-the-fdas-rationale): Why did the FDA restrict peptide compounding in 2023? A plain-English read of the Category 2 decisions and the agency's rationale at the time.

## Compounding
- [How 503A pharmacies compound peptides from API to vial](https://www.halftime.health/learning-center/503a-compounding-process): A 503A pharmacy turns a prescription into a finished peptide vial. Here's the step-by-step look at how that happens — API to vial, plainly explained.
- [How to evaluate a 503A compounding pharmacy: the checklist](https://www.halftime.health/learning-center/503a-evaluation-checklist): A plain-English checklist for evaluating a 503A compounding pharmacy: licensing, accreditation, sourcing, and the questions worth asking before you trust one.
- [503A Compounding FAQ: The Questions Patients and Prescribers Ask](https://www.halftime.health/learning-center/503a-faqs): 503A pharmacies compound medications for individual prescriptions under state license. Here are direct answers to the most common questions about how they work.
- [503A pharmacy quality standards: what to look for](https://www.halftime.health/learning-center/503a-pharmacy-quality-standards): 503A pharmacy quality standards in plain English: USP-797 sterility, PCAB accreditation, certificate of analysis, and licensed-state pharmacist oversight. What to ask before you fill.
- [503A compounding risks: what the 2012–2013 incidents taught us](https://www.halftime.health/learning-center/503a-quality-risks): 503A compounding risks in plain English: what the 2012 NECC outbreak revealed, the reforms that followed, and how a careful 503A pharmacy mitigates risk today.
- [Why 503A pharmacies exist: the oversight history](https://www.halftime.health/learning-center/503a-regulatory-history): 503A pharmacies exist because of a 1997 law, a 2002 Supreme Court ruling, and the 2012 NECC meningitis outbreak that forced Congress to pass the DQSA in 2013.
- [503A vs 503B compounding: the functional difference](https://www.halftime.health/learning-center/503a-vs-503b-explained): 503A and 503B compounding pharmacies are both legal, but they serve different patients in different ways. Here is the practical difference in plain English.
- [503A vs 503B compounding pharmacies explained](https://www.halftime.health/learning-center/503a-vs-503b-pharmacies): 503A pharmacies fill patient-specific prescriptions. 503B outsourcing facilities supply providers at scale. Here's what each means for your compounded peptide prescription.
- [503A compounding vs commercial manufacturing: what is different](https://www.halftime.health/learning-center/503a-vs-commercial): 503A compounding makes patient-specific doses under USP standards, not FDA-approved mass batches. Learn how it differs from commercial drug manufacturing.
- [503A compounding pharmacies: what they are and how they work](https://www.halftime.health/learning-center/503a-what-it-is): 503A compounding pharmacies in plain English — what they do, how they differ from a regular drugstore, the FDA framework that authorizes them, and why they matter for peptide care.
- [Who uses 503A compounding pharmacies and why](https://www.halftime.health/learning-center/503a-who-uses): 503A compounding pharmacies serve a specific population — patients who cannot use commercially available drugs. Here is who they serve and why the model exists.
- [API standards: what goes into a compounded peptide](https://www.halftime.health/learning-center/api-standards-compounded-peptides): The API is the active ingredient inside a compounded peptide. Here is what quality standards apply, why source matters, and how to think about it, plainly.
- [Beyond-use dating: how long a compounded medication stays good](https://www.halftime.health/learning-center/beyond-use-dating-how-long-a-compounded-medication-stays-good): A beyond-use date tells you how long a compounded medication remains usable. Here is what it means, how it differs from an expiration date, and why it matters.
- [The certificate of analysis: how to read a peptide pharmacy's quality paperwork](https://www.halftime.health/learning-center/certificate-of-analysis-peptide-pharmacy): A certificate of analysis is the receipt for what is in your peptide vial. Here is how to read one, what to look for, and which fields actually matter.
- [Beyond the shortage: why compounded peptides still have a role](https://www.halftime.health/learning-center/compounded-peptides-role-post-shortage): The drug shortage designation that opened the door to compounded GLP-1s has changed. Here's what that means for compounded peptides — and what hasn't changed at all.
- [How compounded peptides are made: API to vial](https://www.halftime.health/learning-center/compounding-api-to-vial): How does a compounding pharmacy actually make a peptide vial? A plain-English walk through API sourcing, sterile compounding, fill-finish, and quality testing.
- [How to evaluate a compounding pharmacy before you fill a prescription](https://www.halftime.health/learning-center/compounding-evaluation-guide): How to evaluate a compounding pharmacy: check state licensing, 503A or 503B status, PCAB accreditation, third-party testing, and FDA inspection history.
- [Compounding pharmacy quality: the difference between USP-795 and USP-797](https://www.halftime.health/learning-center/compounding-pharmacy-quality-the-difference-between-usp-795-and-usp-797-standard): USP-795 vs USP-797 explained in plain English: the two standards that govern compounding pharmacy quality, and why injectable peptides require the stricter one.
- [Compounding Quality FAQ: The Pharmacy Standards Questions Answered](https://www.halftime.health/learning-center/compounding-quality-faqs): What actually keeps a compounding pharmacy safe? Direct answers on USP standards, PCAB accreditation, inspections, and how to check quality yourself.
- [Compounding Pharmacy Quality: A History of Oversight](https://www.halftime.health/learning-center/compounding-quality-history): Compounding pharmacy oversight changed after the 2012 NECC outbreak. The 2013 DQSA created the 503A and 503B framework that governs quality today.
- [Who ensures compounding pharmacy quality and how](https://www.halftime.health/learning-center/compounding-quality-who): State boards, USP 797, PCAB accreditation, and FDA inspection authority all shape compounding pharmacy quality. Here is how each layer works.
- [Sterility and Endotoxin Testing in Compounding Pharmacies](https://www.halftime.health/learning-center/compounding-sterility-testing): Sterility and endotoxin testing are two separate checks: one confirms an injectable grows no microbes, the other that it carries no fever-causing fragments.
- [Depyrogenation: how pyrogens are removed from injectables](https://www.halftime.health/learning-center/depyrogenation-explained): Depyrogenation is the removal or destruction of pyrogens, like endotoxins, from injectable equipment. Here's what it is, how dry heat works, and why it matters.
- [Endotoxin testing: the safety check beyond sterility](https://www.halftime.health/learning-center/endotoxin-testing-compounded-peptides): Sterility and endotoxin testing are two different checks. Here's what endotoxins are, why a sterile injection can still contain them, and how testing works.
- [Endotoxin testing: why compounded injectables are screened for pyrogens](https://www.halftime.health/learning-center/endotoxin-testing-why-compounded-injectables-are-screened-for-pyrogens): Endotoxin testing checks injectables for fever-causing bacterial fragments. Here is what pyrogens are, how the test works, and why sterile is not enough.
- [Gray-market research-use-only peptides: the real risk profile](https://www.halftime.health/learning-center/gray-market-peptides-risk): RUO-labeled peptides are not intended for human use. No purity guarantees, no sterility testing, no dosing standards. Here's what the FDA and published literature say.
- [Gray-market peptides: why third-party testing isn't enough](https://www.halftime.health/learning-center/gray-market-peptides-why-third-party-testing-isnt-enough): Gray-market peptide sellers often claim third-party testing proves their products are safe. Here's why that claim doesn't hold up — and what actually matters.
- [Gray-market research peptides: the quality risk explained](https://www.halftime.health/learning-center/gray-market-quality-risk): Research-only peptides sold online skip the checks a licensed pharmacy must pass. Here is the plain-English quality risk that the lower price actually creates.
- [How to choose a quality peptide compounding pharmacy: the quality signals](https://www.halftime.health/learning-center/how-to-choose-a-quality-peptide-compounding-pharmacy-the-quality-signals): Not all compounding pharmacies are the same. Here are the licensing, testing, and procedural signals that separate a quality 503A pharmacy from a problem one.
- [How to read a peptide COA: what third-party lab results really tell you](https://www.halftime.health/learning-center/how-to-read-a-peptide-coa-what-third-party-lab-results-actually-tell-you): A peptide COA looks reassuring, but it only proves so much. Here's how to read a certificate of analysis and what it can't tell you, in plain English.
- [Why peptide vials are nitrogen-flushed: oxidation, explained](https://www.halftime.health/learning-center/nitrogen-flush-peptide-vial-oxidation): Nitrogen flushing removes oxygen from the vial headspace before sealing. Here's why that step protects peptide integrity and what oxidation actually does.
- [Particulate inspection: why vials are checked against light](https://www.halftime.health/learning-center/particulate-inspection-injectables): Particulate inspection is the visual check that screens injectable vials for stray particles. Here is how it works and why it protects patients.
- [How PCAB Evaluates Compounding Pharmacy Quality](https://www.halftime.health/learning-center/pcab-evaluation-process): PCAB reviews compounding pharmacies against USP standards, staff training, and facility controls through document review plus an on-site survey.
- [What PCAB accreditation does not cover: the realistic limits](https://www.halftime.health/learning-center/pcab-limits): PCAB accreditation checks a compounding pharmacy's processes — not every batch's potency. Here is what it verifies and what it cannot tell you.
- [PCAB Accreditation Research: What the Quality Data Shows](https://www.halftime.health/learning-center/pcab-quality-research): PCAB accreditation research: what published quality and sterility data actually show about accredited versus non-accredited compounding pharmacies today.
- [PCAB vs USP: two compounding-quality frameworks](https://www.halftime.health/learning-center/pcab-vs-usp): PCAB is an accreditation; USP sets the standards. Here is the difference between PCAB and USP compounding chapters and why both matter for pharmacy quality.
- [PCAB accreditation vs USP 795/797 compliance: what each covers](https://www.halftime.health/learning-center/pcab-vs-usp-797): PCAB accreditation and USP 795/797 compliance are not the same thing. Here is what each one covers, how they overlap, and why both matter for pharmacy quality.
- [PCAB accreditation explained: what it means for a compounding pharmacy](https://www.halftime.health/learning-center/pcab-what-it-is): PCAB accreditation is a voluntary verification that a compounding pharmacy meets specific quality standards. Here is what it covers — and what it doesn't replace.
- [Who should care about PCAB accreditation and why](https://www.halftime.health/learning-center/pcab-who-cares): PCAB accreditation explained — what it is, who it matters to, and what it actually tells you about a compounding pharmacy's quality standards.
- [Peptide purity: what a COA can and cannot confirm](https://www.halftime.health/learning-center/peptide-purity-what-coa-testing-can-and-cannot-confirm): A peptide certificate of analysis tells you a lot — and leaves a lot out. Here is what HPLC and mass-spec actually confirm, and what they do not.
- [Peptide therapy and the compounding model: how it all fits together](https://www.halftime.health/learning-center/peptide-therapy-compounding-model): How does a peptide actually get from a research compound to your medicine cabinet? A plain-English explanation of the prescription, compounding, and dispensing model.
- [Red flags on a peptide website: a checklist](https://www.halftime.health/learning-center/peptide-website-red-flags-checklist): Eight red flags that signal a peptide website is gray-market or unsafe — and what a legitimate path looks like. Consumer-protection checklist.
- [Research-use-only vs physician-supervised peptides](https://www.halftime.health/learning-center/research-use-only-vs-physician-supervised-peptides-why-the-distinction-matters): Research-use-only peptides are sold for the lab bench, not for people. Here is how they differ from physician-supervised compounded peptides, in plain English.
- [Single-dose vs multi-dose vials: what the difference means](https://www.halftime.health/learning-center/single-dose-vs-multi-dose-vials): Single-dose vials hold one dose with no preservative; multi-dose vials hold several. Here is the difference and why it matters for injection safety.
- [Single-vial peptide combinations: which ones work together](https://www.halftime.health/learning-center/single-vial-combinations): Not all peptides can be combined in one vial. Here's what determines compatibility — pH, diluent stability, dosing schedules — and which combinations are industry-established.
- [Single-vial vs multi-vial peptide combinations: a clinical perspective](https://www.halftime.health/learning-center/single-vial-multi-vial-clinical-perspective): Can two peptides be combined in one vial? Here is how compounding pharmacies decide, what the stability data has to support, and what patients should ask.
- [State pharmacy board vs FDA: who oversees compounding](https://www.halftime.health/learning-center/state-pharmacy-board-vs-fda-roles-compounding-oversight): Compounding has two overseers: state pharmacy boards license the pharmacy day-to-day, the FDA sets federal rules for which substances may be compounded.
- [Sterile filtration: how a 0.22-micron filter works](https://www.halftime.health/learning-center/sterile-filtration-0-22-micron): Sterile filtration removes bacteria from injectable drugs using a 0.22-micron membrane — no heat needed. Learn how the FDA sterilizing-grade standard works.
- [Sterility testing in compounded peptides: what the standards require](https://www.halftime.health/learning-center/sterility-testing-compounded-peptides): Compounded injectable peptides must meet USP <797> sterility standards. Here is what the standards require — and what to look for in a 503A pharmacy.
- [What telehealth peptide prescribing actually looks like](https://www.halftime.health/learning-center/telehealth-peptide-prescribing-process): Curious how telehealth peptide prescribing actually works? Here's the step-by-step process — intake, labs, physician visit, pharmacy, and what to expect.
- [Terminal vs aseptic sterilization: the difference](https://www.halftime.health/learning-center/terminal-vs-aseptic-sterilization): Terminal sterilization sterilizes a drug after it is sealed; aseptic processing keeps it sterile while filling. Here's the difference and which the FDA prefers.
- [Third-party testing for peptides: what verification actually looks like](https://www.halftime.health/learning-center/third-party-testing-peptides): Third-party testing verifies peptide identity, purity, and sterility. Here is what a real certificate of analysis includes and how to tell genuine verification from marketing.
- [Tonicity agents in injectables explained](https://www.halftime.health/learning-center/tonicity-agents-in-injectables): Tonicity agents make an injection match the body's salt balance so it does not damage cells. Here is what they are, why they matter, and the science.
- [USP 795 vs USP 797: the two compounding standards a quality pharmacy follows](https://www.halftime.health/learning-center/usp-795-vs-797-compounding): USP 795 covers nonsterile compounding. USP 797 covers sterile. Here is what each standard requires and why both matter when peptides are involved.
- [Vial coring: what it is and how to prevent it](https://www.halftime.health/learning-center/vial-stopper-coring-explained): Vial coring happens when a needle shaves a fragment of rubber stopper into a vial. Here's what causes it, why it matters, and how to prevent it.
- [Water for injection: pharmaceutical water grades](https://www.halftime.health/learning-center/water-for-injection-grades): Water for injection is the high-purity water used to make and dilute injectable drugs. Here's what the grades mean and why purity is tightly controlled.
- [What happens inside a compounding pharmacy](https://www.halftime.health/learning-center/what-happens-inside-compounding-pharmacy): A walkthrough of what actually happens inside a 503A compounding pharmacy — from the active pharmaceutical ingredient to the labeled vial — in plain English.
- [What PCAB accreditation means for compounding pharmacy quality](https://www.halftime.health/learning-center/what-is-pcab-accreditation): PCAB is a voluntary accreditation for compounding pharmacies covering sterility, quality, and USP 797/800 compliance. Here's what it means and why it matters.
- [What "research-use only" on a peptide vial actually means](https://www.halftime.health/learning-center/what-research-use-only-on-a-peptide-vial-actually-means): A research-use-only label is not a wink-and-nod prescription. Here is what RUO actually means, who can legally buy these vials, and why the label is a warning.
- [What 'research-use only' on a peptide vial actually means](https://www.halftime.health/learning-center/what-research-use-only-on-peptide-vial-actually-means): Research-use only on a peptide vial, in plain English — what the label really means, what it does not, and why it is not a clinical pathway for patients.
- [Why a compounded medication is not a generic drug](https://www.halftime.health/learning-center/why-a-compounded-medication-is-not-a-generic-drug): Compounded and generic drugs are often confused, but they follow different rules. Here is the plain-English difference and why it matters for you.

## Sexual Health
- [Bremelanotide is FDA-approved for women: what Vyleesi actually treats](https://www.halftime.health/learning-center/bremelanotide-vyleesi-fda-approved-women): Bremelanotide (Vyleesi) is FDA-approved for premenopausal women with HSDD. The branded form is FDA-approved; compounded PT-141 is not. What the label actually covers, in plain English.
- [Why ED is a vascular problem first](https://www.halftime.health/learning-center/ed-vascular-problem-first): Erectile dysfunction is most often a blood flow issue before anything else. Here is what the cardiology research links it to and why screening matters.
- [Who should be screened for vascular causes of ED](https://www.halftime.health/learning-center/ed-vascular-screening): ED is often the first symptom of artery disease, sometimes years before a heart attack. Here is the group of men whose ED deserves a real cardiovascular workup.
- [Erectile dysfunction as a vascular health signal](https://www.halftime.health/learning-center/ed-vascular-signal): Erectile dysfunction often shows up years before a cardiovascular event. Why ED is a vascular signal worth taking seriously. Educational only.
- [Erectile dysfunction as a vascular-health signal](https://www.halftime.health/learning-center/erectile-dysfunction-vascular): ED frequently precedes cardiovascular events by two to five years. Endothelial dysfunction is the shared mechanism. Here's what the published research says about ED as a screening opportunity.
- [Who asks about female libido and what they want to know](https://www.halftime.health/learning-center/female-libido-who-asks): Who searches for female libido treatments, why low desire is underdiagnosed, and what the research says about causes and clinical options for women over 40.
- [HSDD explained: female sexual arousal and the brain-body link](https://www.halftime.health/learning-center/hsdd-female-sexual-arousal-explained): HSDD explained — what hypoactive sexual desire disorder is, how the brain-body desire pathway works, and where peptides like bremelanotide fit in clinically.
- [Intimacy, cortisol, and libido: the stress connection](https://www.halftime.health/learning-center/intimacy-cortisol-libido-stress-connection): Chronic stress reshapes hormones, sleep, and attention — three of the strongest inputs to libido. Here is what the research links and where peptides fit.
- [Intimacy and stress: how cortisol suppresses desire](https://www.halftime.health/learning-center/intimacy-stress-cortisol-desire): Chronic stress raises cortisol, which suppresses sex hormones and desire in both men and women. Here's the mechanism and what the research shows.
- [Low libido in men: what to investigate before reaching for a pill](https://www.halftime.health/learning-center/low-libido-men-causes-before-treatment): Low libido in men is rarely just a libido problem. The plain-English checklist a clinician runs through before testosterone, peptides, or anything else.
- [Low libido in women: how hormones, stress, and peptides intersect](https://www.halftime.health/learning-center/low-libido-women-hormones-stress-peptides): Low libido in women is rarely a single-cause problem. Hormones, stress biology, relationship factors, and medications all play a role. A plain-English map of how peptides fit in.
- [The melanocortin system: why PT-141 works at the brain level](https://www.halftime.health/learning-center/melanocortin-system-pt-141-brain): PT-141 acts on the brain's melanocortin system, not on blood flow. Here is how the MC4R pathway connects to sexual desire — and what makes it unlike Viagra.
- [Melanotan II: what the literature says about risks](https://www.halftime.health/learning-center/melanotan-2-risks): Melanotan II is not FDA-approved and not available from 503A compounding pharmacies. Here is what the published case literature says about documented adverse events.
- [Who asks about melanotan-2 and what draws them to it](https://www.halftime.health/learning-center/melanotan-2-who-asks): Melanotan-2 is an unapproved peptide linked to tanning and libido claims; here's who asks about it, why, and the safety facts (FDA, MHRA, TGA).
- [Melanotan II vs PT-141: why the FDA approval difference matters](https://www.halftime.health/learning-center/melanotan-ii-vs-pt-141-why-the-fda-approval-difference-matters): Melanotan II and PT-141 came from the same molecule family — but only one is FDA-approved. Here is what the regulatory split means for patients.
- [Oxytocin beyond bonding: stress, intimacy, and the research](https://www.halftime.health/learning-center/oxytocin-beyond-bonding-research): Oxytocin is more than the bonding hormone. What the published research says about its role in stress, trust, and intimacy — and where the data gets thin.
- [Oxytocin beyond the stereotype: a peptide primer](https://www.halftime.health/learning-center/oxytocin-intimacy): Oxytocin is more than the 'love hormone' label suggests. Here's the neuroscience — pituitary origin, social bonding studies, and what the intranasal research actually shows.
- [Oxytocin research: intimacy, bonding, and sexual health in the literature](https://www.halftime.health/learning-center/oxytocin-research): Oxytocin research goes well beyond labor and breastfeeding. Trials explore bonding, trust, and sexual function. Here is what the published literature shows.
- [Oxytocin vs PT-141: two different paths to intimacy biology](https://www.halftime.health/learning-center/oxytocin-vs-pt-141): Oxytocin vs PT-141 — how a bonding hormone differs from a melanocortin desire signal. Bremelanotide is FDA-approved as Vyleesi; the compounded form is not.
- [Who asks about prescription oxytocin and why](https://www.halftime.health/learning-center/oxytocin-who-asks): Oxytocin is a hormone the body makes, studied for bonding and intimacy. Here's who asks about prescription oxytocin and what the research shows.
- [How PDE5 inhibitors boost nitric oxide and blood flow](https://www.halftime.health/learning-center/pde5-mechanism): How PDE5 inhibitors like sildenafil and tadalafil (FDA-approved prescription drugs, not compounded peptides) block an enzyme to keep blood vessels relaxed.
- [PDE5 inhibitor side effects and contraindications](https://www.halftime.health/learning-center/pde5-side-effects): PDE5 inhibitor side effects in plain English — headache, flushing, vision changes, blood pressure drops, and the nitrate interaction every prescriber screens for.
- [What PDE5 inhibitors are and how they work](https://www.halftime.health/learning-center/pde5-what-they-are): PDE5 inhibitors explained: what they are, how they work at the molecular level, and how they fit into the broader landscape of men's sexual health options.
- [PT-141 dosing and timing: a clinical overview](https://www.halftime.health/learning-center/pt-141-dosing-timing-clinical): PT-141 dosing and timing explained: onset, peak, nausea window, and dose limits. Bremelanotide is FDA-approved as Vyleesi; compounded PT-141 for men is not FDA-approved.
- [PT-141 FAQ: the sexual health peptide questions answered](https://www.halftime.health/learning-center/pt-141-faqs): PT-141 questions answered in plain English: timing, dose, who it works for, side effects, women vs men, and how it differs from ED pills like sildenafil.
- [PT-141 for women: what the bremelanotide research shows for female desire](https://www.halftime.health/learning-center/pt-141-for-women-what-the-bremelanotide-research-shows-for-female-sexual-desire): PT-141 (bremelanotide) is the only FDA-approved injectable for low sexual desire in premenopausal women. Here is what the research actually shows, in plain English.
- [How PT-141 signals desire through melanocortin receptors](https://www.halftime.health/learning-center/pt-141-mechanism): How does PT-141 work? Unlike PDE5 inhibitors, bremelanotide acts in the brain, not the bloodstream. A plain-English walk through melanocortin receptor signaling.
- [PT-141 research: bremelanotide in the published literature](https://www.halftime.health/learning-center/pt-141-research): PT-141 (bremelanotide) is a melanocortin receptor agonist with FDA approval for one specific indication in women. Here is what the PT-141 research literature actually shows.
- [PT-141 side effects: what the literature reports and how nausea is managed](https://www.halftime.health/learning-center/pt-141-side-effects): Vyleesi (bremelanotide / PT-141) is FDA-approved for one use; the compounded version is not FDA-approved. Here is what the side effect literature shows.
- [PT-141 side effects: what to expect and how nausea is managed](https://www.halftime.health/learning-center/pt-141-side-effects-nausea-management): PT-141 side effects in plain English: nausea, flushing, and blood pressure changes — and how clinicians typically address them. Not FDA-approved.
- [PT-141 vs melanotan-2: what makes bremelanotide different](https://www.halftime.health/learning-center/pt-141-vs-melanotan-2): PT-141 vs melanotan-2 in plain English — same family, different design, different approval status. Why bremelanotide is FDA-approved and melanotan-2 is not.
- [PT-141 vs sildenafil: two different mechanisms for two different problems](https://www.halftime.health/learning-center/pt-141-vs-sildenafil-mechanism-comparison): PT-141 vs sildenafil in plain English: a brain peptide that signals desire vs a vascular drug that supports erection. Two mechanisms, two different problems, side by side.
- [PT-141 (bremelanotide): how melanocortin signaling affects desire](https://www.halftime.health/learning-center/pt-141-what-it-is): PT-141 (bremelanotide) is the active ingredient in Vyleesi (FDA-approved for HSDD); compounded versions are not FDA-approved. How the melanocortin pathway works.
- [Who asks about PT-141 and the questions behind the search](https://www.halftime.health/learning-center/pt-141-who-asks): People searching for PT-141 are usually asking about low libido that has not responded to other approaches. Here is who asks and what they want to know.
- [PT-141 for women: the brain-based path to desire](https://www.halftime.health/learning-center/pt-141-women-brain-desire): PT-141 (bremelanotide) acts in the brain — not in the bloodstream — and the FDA-approved version is indicated for premenopausal HSDD. Here is the plain-English breakdown.
- [Spontaneous vs responsive desire: two normal patterns](https://www.halftime.health/learning-center/spontaneous-vs-responsive-desire): Spontaneous desire arises on its own. Responsive desire shows up after intimacy begins. Both are normal. Here's what the research says about these two patterns.
- [The vascular theory of ED: why blood flow comes before anything else](https://www.halftime.health/learning-center/vascular-theory-ed-blood-flow-first): Erectile dysfunction is most commonly a vascular issue — not a psychological one. Understanding the blood flow mechanism changes how clinicians and patients approach it.
- [Why men's sexual health is a cardiovascular screening opportunity](https://www.halftime.health/learning-center/why-mens-sexual-health-is-a-cardiovascular-screening-opportunity): Erectile dysfunction often appears years before a cardiac event. Research shows it's a vascular signal — here's what the data says and what to do with it.

## Injection FAQs
- [Air bubble in a peptide syringe: does it matter?](https://www.halftime.health/learning-center/air-bubble-peptide-syringe): Air bubble in a peptide syringe in plain English: why a small bubble in subcutaneous injection is generally harmless, and how to expel one for dose accuracy.
- [Bacteriostatic water vs sterile water: how to reconstitute peptides](https://www.halftime.health/learning-center/bacteriostatic-vs-sterile-water): Bacteriostatic water vs sterile water — what each is, when each is used to reconstitute peptides, and why benzyl alcohol matters. Plain-English injection guide.
- [How subcutaneous peptide injections work](https://www.halftime.health/learning-center/how-peptide-injections-work): Subcutaneous peptide injections deliver compounds below the skin for stable, predictable absorption. Here's how the mechanism works and what to expect.
- [How to give your first peptide injection](https://www.halftime.health/learning-center/how-to-give-first-peptide-injection): A plain-English walkthrough of how to give your first subcutaneous peptide injection — prep, angle, site, and aftercare in under five minutes.
- [Needle gauge and length for peptide injections: a reference guide](https://www.halftime.health/learning-center/injection-needle-guide): Which needle do you use for a peptide injection? A plain-English reference to needle gauge and length for subcutaneous peptide administration.
- [Minimizing injection pain: what the research supports](https://www.halftime.health/learning-center/injection-pain-minimizing): Evidence from diabetes injection research points to several techniques associated with less injection discomfort. Here's what the literature actually supports.
- [Injection pain research: what the literature says](https://www.halftime.health/learning-center/injection-pain-research): What the published research shows about subcutaneous injection pain: causes, which factors reduce discomfort, and what to expect from a typical protocol.
- [Injection site reactions: what is normal and what to report](https://www.halftime.health/learning-center/injection-site-reactions): Redness, a small bump, or mild itch at a peptide injection site is usually normal. The line between expected reactions and something to call a clinician about.
- [Injection site reactions: what's normal and what's not](https://www.halftime.health/learning-center/injection-site-reactions-normal-vs-not): Injection site reactions explained: which bumps, redness, and itching are normal after a peptide injection, and which signs deserve a clinician call.
- [Injection site rotation: why it matters](https://www.halftime.health/learning-center/injection-site-rotation): Rotating injection sites prevents lipohypertrophy and keeps absorption consistent. Here's a practical rotation pattern for abdominal and thigh sites.
- [How subcutaneous peptide injections actually get absorbed](https://www.halftime.health/learning-center/injection-subcutaneous-absorption): Why most peptides are injected into the fat layer under the skin, how the molecule travels from there to the bloodstream, and what makes the timing predictable.
- [Injection technique FAQ: the questions beginners ask](https://www.halftime.health/learning-center/injection-technique-faqs): New to self-injection? Here are plain-English answers to the most common technique questions, from needle angle and pinch to site rotation and disposal.
- [How subcutaneous peptide injections work: a plain-English primer](https://www.halftime.health/learning-center/injection-technique-primer): A subcutaneous peptide injection sits just under the skin in fatty tissue. Here is what that means in plain English and why peptides need an injection.
- [Who asks about peptide injection technique and why](https://www.halftime.health/learning-center/injection-who-asks): Most people starting a peptide protocol have never given themselves an injection. Here is who asks about technique, what worries them, and what matters.
- [Insulin syringes for peptide injections: a practical guide](https://www.halftime.health/learning-center/insulin-syringe-guide-peptides): Most peptide subcutaneous injections use insulin syringes. Here's how to read the unit markings, pick the right size, and use them correctly.
- [Needle gauge guide: which size for which peptide injection](https://www.halftime.health/learning-center/needle-gauge-guide-peptide-injections): Most peptide injections use a 29 to 31 gauge insulin syringe. Here is what the gauge number means, which size fits which use, and how to pick for comfort.
- [Peptide storage and cold chain basics](https://www.halftime.health/learning-center/peptide-storage-cold-chain): Compounded peptides are temperature-sensitive. Here's how to store unopened and reconstituted vials correctly, and what to know about cold-chain shipping.
- [Reconstituted peptide shelf life: how long is the vial good for?](https://www.halftime.health/learning-center/reconstituted-peptide-shelf-life): Reconstituted peptide shelf life — how long the vial stays good, what shortens it, how cold storage helps, and how to tell when a vial should not be used.
- [How peptides are reconstituted: bacteriostatic water basics](https://www.halftime.health/learning-center/reconstituting-peptides): Lyophilized peptides must be reconstituted before injection. Here's how bacteriostatic water works, why it differs from sterile water, and how to do it correctly.
- [The complete reconstitution walkthrough, step by step](https://www.halftime.health/learning-center/reconstitution-walkthrough-step-by-step): Reconstitution means mixing a freeze-dried peptide with sterile water. Here is what the step-by-step process involves and why it matters, in plain English.
- [The science of subcutaneous injection: why the fat layer works](https://www.halftime.health/learning-center/science-subcutaneous-injection-fat-layer): Subcutaneous injections deliver medication into the fat layer just under the skin. Here's the science of why that works — and how absorption actually happens.
- [Self-injection vs clinic administration: what the evidence supports](https://www.halftime.health/learning-center/self-injection-vs-clinic): At-home subcutaneous injection vs clinic visits — what does the evidence from insulin and biologic research actually show about safety, adherence, and cost?
- [How to dispose of needles and sharps safely](https://www.halftime.health/learning-center/sharps-disposal-compliance): Never put loose needles in the trash. Here's how to use an FDA-cleared sharps container and find a disposal site in your state — step by step.
- [Subcutaneous vs intramuscular injection: what the research shows](https://www.halftime.health/learning-center/subq-vs-im-comparison): Subcutaneous vs intramuscular injection for peptides: what the research shows about absorption, onset, and why most protocols use one over the other.
- [Subcutaneous vs intramuscular peptide injections: when each is used](https://www.halftime.health/learning-center/subq-vs-im-peptide-injections-when-each-is-used): Most peptide protocols use subcutaneous injection — small needle, into fat. A few use intramuscular. Here is the difference and where each one fits.
- [Traveling with peptides: cold chain, TSA, and dosing on the road](https://www.halftime.health/learning-center/traveling-with-peptides): Traveling with prescription peptides is straightforward if you plan the cold chain and the documentation. Here is the plain-English checklist for flights, road trips, and time-zone shifts.
- [What to do if you miss a peptide dose](https://www.halftime.health/learning-center/what-to-do-miss-peptide-dose): Missed a peptide dose? Here is a plain-English guide to what usually happens, what clinicians generally advise, and why you should not double up on your own.
- [Where to store peptides: refrigerator rules and freezer limits](https://www.halftime.health/learning-center/where-to-store-peptides-refrigerator): Peptide storage is simple once you know two rules: lyophilized powder tolerates cold storage; reconstituted peptides do not tolerate freezing. Here's the full guide.

## Founder's Voice
- [Why we're building Halftime Health](https://www.halftime.health/learning-center/why-halftime-exists): Why we're building a peptide telehealth company that tries to be more boring and more credible than most of what exists in this space right now.